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Abstract
Mild traumatic brain injury (mTBI) has become a focal point within the medical community
due to its increased prevalence in recent years. Unfortunately, there is currently no
neuroimaging technique able to accurately diagnose and monitor mTBI in-vivo. One
technique that has shown great promise is neurite orientation dispersion and density imaging
(NODDI). NODDI is a diffusion MRI (dMRI) technique used to characterize microstructural
complexity through the compartmental modelling of neural water fractions into Intra-neurite,
Extra-neurite and CSF volume fractions. The overreaching theme of this thesis was to
validate NODDI in a preclinical setting to then be applied to imaging of early mTBI. In the
first study, NODDI was shown to have high precision and repeatability both between and
within subject. Furthermore, it was found that small biological changes (<5%) may be
detected with feasible sample sizes for NODDI metrics indicating it to be a useful tool within
the preclinical research setting at 9.4 Tesla. Following this validation NODDI was used to
image the early stages of mTBI in a rodent model. NODDI was able to detect changes in
neurite microstructure within the first hour on mTBI. Following this successful application,
NODDI was applied to a rodent model of repetitive mTBI. Many athletes experience
multiple mTBI’s over the course of a season and the cumulative effect of these injuries is still
unknown. NODDI was successfully able to detect altered water diffusion characteristics in
the brain of rodents following both a first a second mTBI. Converse to our hypothesis, the
measured changes did not differ between the first and second impact on a group wise scale.
These changes reinforce our previous findings showing an immediate change to the
microstructure of the brain following an initial mTBI, and further this knowledge by
indicating a heterogeneous individual response to the second mTBI. Further it was shown
that some of these changes did not return to normal between the two injuries, potentially
providing a window into the changes within the brain.
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Lay Summary
Mild traumatic brain injury (mTBI) has become an important public health concern as these
injuries have become increasingly common in recent years. Unfortunately, there is no current
medical imaging technique that allows accurate diagnosis and monitoring of mTBI. This is
because many neuroimaging techniques such as computed tomography (CT) and positron
emission tomography (PET) lack the specificity to identify the subtle damage present in the
brains of those suffering from mTBI. Magnetic resonance imaging (MRI) is a good candidate
to identify these changes due to its strong soft tissue contrast. One specific MRI technique
that has shown promise in detecting subtle brain microstructural changes is neurite
orientation dispersion and density imaging (NODDI). NODDI is able to quantify the density
and spatial organization of various anatomical structures in the brain such as axons and
dendrites and as such presents an opportunity to monitor brain health after injury. In this
thesis, NODDI was first developed for use in a preclinical MRI setting. As animal models
present a unique opportunity to study the extremely early stages of mTBI it was first
necessary to redevelop this technique from clinical use in humans to rodent use in a
preclinical MRI scanner. Once NODDI was validated for pre-clinical use it was then applied
in the extremely early stages of a rodent model of mTBI. NODDI was able to detect changes
in the neuronal structures of rodents within the first hour of mTBI, representing a potential
opportunity to map out these changes over time. Following this successful application,
NODDI was applied to a rodent model of repetitive mTBI, a model particularly relevant to
sporting situations. Many athletes experience multiple mTBI’s over the course of a season
and the cumulative effect of these injuries is still unknown. NODDI was able to detect
extremely early changes in the brain of rodents after both a first and second mTBI. Further it
was shown that some of these changes did not return to normal between the two injuries,
potentially providing a window into the changes within the brain.
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Chapter 1
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Introduction
1.1 Background and Motivation
Awareness of the immediate and long-term detrimental effects of mild traumatic brain
injury (mTBI) has increased recently. Currently there is no pathognomonic test that
allows diagnosis of mTBI and subsequent monitoring of recovery. Clinical assessments
focus on self-reported patient symptoms but unfortunately provide little with regard to the
underlying biological changes that lead to these symptoms [1–4]. Further, it is nearly
impossible to study the immediate (1-2 hours) changes in a clinical setting as patients
simply aren’t available for study during this time period. Thus, we are left with a vague
understanding of the pathological processes taking place in the immediate stages of
mTBI. To develop unbiased metrics of mTBI that can inform diagnosis we must
understand the underlying metabolic and microstructural features of these injuries.
Currently there are many medical imaging techniques available that can be used to noninvasively image the body. Unfortunately though, most are unable to image mTBI as
large scale changes such as expanding epidural hematoma are absent [5,6]. Magnetic
resonance imaging (MRI) is ideally suited for imaging the soft tissues within the brain
and thus is widely used in the study of mTBI [7,8]. Various MRI techniques have been
carefully developed that provide accurate and detailed in-vivo information about changes
in the structure [9,10], metabolism [11,12], and function [13,14] of the brain due to
mTBI. Despite these capabilities, imaging mTBI in-vivo is still limited in individual
patients due to small physical size and heterogeneous distribution of injury markers in the
brain [15]. Moreover, many microstructural abnormalities such as white matter lesions
are found in a large percentage of healthy middle-aged individuals, further compounding
the difficulty in detection of microstructural changes specific to mTBI [16]. Thus, there is
a need to develop techniques that are sensitive specifically to microstructural changes in
mTBI. One modality that has been shown to be effective in the detection of
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microstructural changes in mTBI is diffusion magnetic resonance imaging (dMRI). dMRI
is a powerful magnetic resonance modality that can probe anatomical microstructure and
structural connectivity within the normal brain and following injury or pathology [17].
dMRI has been used extensively to study various forms of brain injury including mTBI
and has been able to detect alterations in diffusion patterns of water years after initial
injury in the clinical setting [18–20], and within 4 hours of injury in the pre-clinical
setting [21]. Despite this, no current studies have attempted to use dMRI withing the first
hour following an injury. Furthermore, the changes in these metrics have been
inconsistent due to the heterogeneous nature of mTBI pathological changes [22–26]. To
disentangle these features various advanced biophysical models have been proposed
which model the diffusion signal in a biologically relevant form such as the composite
hindered and restricted model of diffusion (CHARMED), white matter tract integrity
(WMTI), and neurite orientation dispersion and density imaging (NODDI) [27–29].
NODDI is a biophysical model that separates the dMRI signal into three unique
compartments termed intra-neurite, extra-neurite and CSF compartments [30]. The intraneurite compartment is representative of dendrites and axons, while the extra-neurite
compartment is comprised of various cell bodies, areas in close proximity to neurons, and
glial cells. The CSF compartment is simply the area taken up by freely diffusing water.
This model allows detection of neuronal changes separate from changes within the extraneurite compartment. Thus, NODDI is well situated to image mTBI in-vivo in an attempt
to understand the various pathological processes taking places in the immediate stages
following mTBI.

1.2 Thesis Objectives and Organization
This thesis describes the process by which NODDI has been used to image various
pathological changes in mTBI in-vivo at 9.4 Tesla in a rodent model of traumatic brain
injury (TBI). Contained in this work is the first quantification of the reproducibility of
NODDI in a rodent model at 9.4 Tesla, the first time NODDI (or any dMRI technique)
has evaluated the temporal changes of diffusion characteristics within the brain of a
rodent from hours 1-4 following a mTBI, and the first time the effect of repetitive mTBI
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on diffusion characteristics within the rodent brain has been quantified with NODDI (or
any dMRI technique) within the first hour of both an initial and secondary mTBI. This
thesis requires an understanding of neuroanatomy, mTBI, MRI, dMRI, and NODDI.
Therefore, a brief review of the relevant neuroanatomy is described, specifically that
needed for the discussion of TBI in chapter 1.3. In chapter 3 the focus will shift to an
overview of MRI in isolation followed by a description of diffusion processes and dMRI
in chapter 4. Finally, in chapter 5, I will show how dMRI can exploit biophysical models
to create a biologically relevant image using NODDI.
The overall objective of this work is to develop Neurite orientation dispersion and density
imaging into a viable dMRI technique applicable to detection of subtle microstructural
changes in pre-clinical rodent models of mild traumatic brain injury using high field
MRI. We hypothesized that NODDI will be sensitive to early microstructural changes in
the brain in a rodent model of mTBI. Secondary to this objective, we aimed to determine
whether NODDI metrics provided greater sensitivity than standard dMRI metrics to
changes in the brain following mTBI in a rodent model. The following provides a
summary of the specific objectives contained within each chapter of this thesis.
Chapter 2 characterizes the reproducibility of NODDI in a rodent model at 9.4 Tesla.
When this work began, no attempt had been made to determine either the feasibility or
reproducibility of obtaining NODDI metrics at 9.4 Tesla in a rodent brain. As ultra-high
field MRI presents many unique challenges, such as increased main magnetic field
inhomogeneity and physiological artefacts, it was necessary to first determine the
reproducibility and the utility (as determined by necessary sample sizes and measurable
biological effects) of NODDI in this model.
Chapter 3 presents the first application of NODDI to a pre-clinical rodent model of mTBI
at 9.4 Tesla. We hypothesized that NODDI would detect changes in water diffusion
indicating changes in the microstructure of the brain within the first 4 hours of mTBI.
Further, we hypothesized that NODDI would be more sensitive to these changes than
standard DTI metrics.
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In Chapter 4 we extend the model of rodent TBI used in Chapter 3 to study the early
microstructural changes present in a rodent model of repetitive mTBI. We hypothesized
that NODDI would be able to detect water diffusion changes indicating microstructural
changes in a rodent model of repetitive mTBI 9.4 Tesla. Furthermore, we hypothesized
that these changes would be unique after an initial and secondary mTBI.
Finally, in Chapter 5, the findings of this thesis are summarized and synthesized,
particularly the novel contributions of this work to the field. A discussion of the current
state of NODDI as a neuroimaging technique to study mTBI in both a clinical and preclinical model is also provided. The thesis concludes with a discussion of future
directions for this work.

1.3 Neurons and Mild Traumatic Brain Injury
1.3.1

Neurons, Glial Cells, and the Blood Brain Barrier

The Nervous System may be broadly defined as the communication center of a body.
Within the nervous system there are two major classes of cells: neurons and glial cells.
Neurons process and transmit information within the nervous system in the form of an
action potential, enabling communication throughout the body. Glial cells on the other
hand provide mechanical and metabolic support to the neurons, amongst various other
processes.
Neurons are made up three distinct parts: a cell body (or soma), an axon, and dendrites.
The cell body houses the nucleus and associated intra-neurite structures and acts to
integrate and organize various input stimuli. The axon and dendrites may be collectively
referred to as neurites and are mainly responsible for collecting stimuli from
neighbouring neural cells (dendrites) and transmitting signals from the cell body to the
synapse (axon). For a more in depth overview of the nervous system please refer to [31].

5

Figure 1.1 - General representation of the neuron including cell body, axon dendrites
and axon terminal. Here we term the axons and dendrites collectively as neurites.
Glial cells are largely divided into two categories: microglia and macroglia, the latter of
which contains astrocytes and oligodendrocytes. Glial cells reside in the space near
neurons and function as the resident immune cells within the brain and act to modulate
neurotransmission at the synaptic level [32]. Further, they act to form myelin and insulate
neurons, supply nutrients and oxygen to neurons, destroy pathogens, and various other
dynamic processes essential to the healthy functioning of the central nervous system [33–
35]. Additionally, in many pathological processes such as mTBI, glial cells are essential
in mediation of the neuroinflammatory response [36].
In addition to neurons and glial cells, the blood vessels of the CNS possess unique
properties which allow highly specific regulation of the movement of molecules, ions,
and cells from the vasculature to the brain [37]. Termed the blood brain barrier (BBB),
the properties of these blood vessels enable careful maintenance of homeostasis and
protection from pathogens and toxins [38]. This control is highly coordinated and
responds continuously and dynamically to various chemical and electrical stimuli to
protect and support the brain and CNS [39].

1.3.2

Neurons, Glia, and the Blood Brain Barrier during Mild Traumatic
Brain Injury

Traumatic brain injury (TBI) refers to a wide variety of damage to the brain caused either
directly or indirectly by a sudden impact, generally to the head itself, resulting in the
disruption of normal brain function [5]. TBI has a long history of study within the
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neuroscience community. However, there is still no pathognomonic test that can be used
to accurately diagnose or assess TBI. This is particularly important in mTBI, which lacks
obvious pathological presentations during the early phase of injury when decisions
regarding treatment and return to play in sport are most critical [40,41]. Many different
efforts have attempted to develop diagnostic criteria through observation of the complex
cascade of metabolic, physiological, and behavioral effects associated with mTBI, but
currently with limited success [42–44]. Current diagnosis relies on patient self-reporting,
and qualitative symptom assessment in an effort to manage recovery, which leaves the
possibility of unknowingly biased and unreliable assessments [45,46]. Thus, to enable
clinicians to offer accurate patient diagnosis and prognosis it is necessary to develop
unbiased metrics of mTBI. This thesis attempts to elucidate such metrics by focusing on
changes in tissue microstructure that may be associated with alterations to neurons, glia,
and the blood-brain barrier in the very early phase of mTBI.
There are many changes to neurons that have been shown to accompany mTBI. The most
common is neuronal cell death [47], but many others have been observed such as axonal
beading [48], and demyelination and remyelination [49]. Each of these processes has
been shown in various stages and to various degrees in mild traumatic brain injury [50–
55]. Further, axonal beading and swelling has been shown to occur within the first hour
of injury, albeit in varied models and to our knowledge not yet in a closed head model of
mTBI [56,57]. Unfortunately, it is still unclear what effect these processes have in terms
of assessing the severity of mTBI and subsequent recovery.
In addition to neuronal changes, glial cells are known to act in both a neuroprotective and
neurodegenerative manner over the course of injury and recovery in mTBI [58].
Following injury, microglia undergo morphological changes which can produce
neuroprotective factors and coordinate neurorestorative processes or can become
dysregulated and produce pro-inflammatory and cytotoxic mediators that hinder repair
[59]. Astrocytes respond to mTBI by undergoing reactive astrogliosis which aims to limit
tissue damage and restore homeostasis, but may also inhibit adaptive neural plasticity
mechanisms underlying recovery [60,61]. Oligodendrocytes are uniquely vulnerable to
damage under pathological processes and show various patterns of apoptosis and
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dysfunction following mTBI [62–65]. Further, in the acute inflammatory phase BBB
disruption and leakage takes place contributing to infiltration of blood-borne leukocytes,
blood plasma proteins, and macrophages [66–68]. BBB disruption can occur within
minutes following mTBI [69–71], with various neuroinflammatory processes occurring
within several hours if initial injury [72,73].
Despite the importance of these pathological processes in mTBI, much of our current
knowledge is confined to ex-vivo histological samples leaving a gap in our knowledge of
the dynamic properties of neurites, glial cells, and the blood brain barrier. As NODDI’s
biophysical model separately quantifies the changes in neurite volume and orientation,
this technique is well suited to detect and monitor the progression of changes in neurite
structure in-vivo in mTBI. Further, neuroinflammatory processes and blood brain barrier
disruption would take place within the extra-neurite compartment, once again allowing
this technique to provide a detailed in-vivo look at the dynamic processes taking place in
mTBI. Finally, as NODDI allows in-vivo imaging by which we might detect various
dynamic changes within the neural microstructure, careful study of the immediate effects
of mTBI on neurons, glia and the blood barrier to injury is possible. This in turn could
lead a more thorough understanding of the nervous system’s response to mTBI and
potential interventions to improve patient recovery and outcomes.

1.4 MRI – Nuclei, Magnetization, and Avoiding Quantum
Mechanics
All discussions of MRI must first begin with the discussion of the phenomenon of nuclear
magnetic resonance (NMR). While the bulk properties of MRI take place on a
macroscopic level and are thus well explained in the realm of classical physics, it is
important to understand (in brief) the basis of the quantum mechanical description of
NMR and how we extend this description into the realm of classical physics. Thus, this
first chapter begins with a brief description of the quantum mechanical properties of
nuclei and magnetization and transitions into a discussion of bulk magnetization and
manipulation of particle ensembles to generate a measurable NMR signal for use in MRI.
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All discussions and derivations in this chapter rely heavily on those presented in
references [74–77].

1.4.1

Brief Description of “Spin”

All atomic and sub-atomic particles possess an intrinsic property known as spin angular
momentum, or simply spin. This quantum mechanical property is highly analogous to the
classical property of the angular momentum of a sphere rotating about some axis. There
are several distinctions though to be made: spin is an intrinsic property of a particle and
quantized in discrete states. It does not, in fact, represent the physical motion (rotation) of
the particle in question.

1.4.2

Spin and the Magnetic Moment I – Quantum Mechanics

Individual particle spin is a quantum mechanical phenomenon. Spinning charge produces
a magnetic field and thus a magnetic moment 𝜇⃗ in the direction of 𝐽⃗ (the angular
momentum of the proton) such that:
𝜇⃗ = 𝛾 ∙ 𝐽⃗

(1)

Here 𝛾 is the gyromagnetic ratio, a proportionality constant dependent upon the nucleus.
For hydrogen (particularly relevant in MRI),
𝛾 = 2.675 𝑥 10$ 𝑟𝑎𝑑⁄𝑠 ∙ 𝑇

(2)

The hypothetical measurement of a single spin relies on a quantum mechanical
description of angular momentum such that
𝐽 = ℏA𝐼(𝐼 + 1)
Where 𝐼 is the spin quantum number of the nucleus and may only take on discrete half
integer values (I = 0, 1/2, 1, 3/2, …), ℏ = ℎ⁄2𝜋, and ℎ = 6.6 𝑥 10!"# 𝐽𝑜𝑢𝑙𝑒 ⁄𝑠 (Planck’s
constant). Thus, by quantum mechanics, the magnitude of the magnetic moment of a
particle is simply a constant:

(3)
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𝜇 = 𝛾ℏA𝐼(𝐼 + 1)

(4)

For MRI, and particularly diffusion weighted MRI, we generally focus solely on
hydrogen nuclei that possess a spin quantum number 𝐼 = ± 1⁄2. Therefore, we find for
the hydrogen nucleus, there are two distinct energy states:
𝐽 = ± ℏ √3⁄2

(5)

𝜇 = ± 𝛾ℏ √3⁄2

(6)

We say spin energy is quantized as only one of these two states may be observed for a
single spin at a single moment in time.
Without influence from external factors, the orientation of the magnetic moment
O⃗ will
is random. However, interaction of the magnetic moment 𝜇⃗ with a magnetic field 𝐵
O⃗ such that the torque on the particle is defined as:
cause 𝜇⃗ to precess around 𝐵
O⃗
𝜏⃗ = 𝜇⃗ × 𝐵

(7)

This is true for each individual particle within the field. The torque may also be described
by Newtons Second Law as the time rate of change of the angular momentum:
𝑑𝐽⃗ 1 𝑑𝜇⃗
=
𝑑𝑡
𝛾 𝑑𝑡

(8)

Therefore, we obtain the following equation of motion for a spin in a magnetic field:
𝑑𝜇⃗(𝑡)
O⃗ (𝑡)
= 𝛾𝜇⃗(𝑡) × 𝐵
𝑑𝑡

(9)

The precessional frequency of the magnetic moment induced by the magnetic field,
known as the Larmor Frequency is defined as:
𝜔% = 𝛾𝐵%

(10)
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Further to this discussion, the quantization of energy tells us that the magnetic moment of
a proton in an external magnetic field may be measured in only one of two states. The
magnetic moment may precess around an axis parallel to the main magnetic field (known
as the “spin up” state) or the magnetic moment may precess around an axis antiparallel to
the main magnetic field (known the “spin down” state). While both states occur naturally,
the spin up is at a lower energy state to the spin down, and thus preferentially populated.
The distribution of the nuclei into these states will be discussed later and is governed by
Boltzmann statistics.
Thus, we see the basis for the origin of the magnetic moment due to spin angular
momentum and its interaction with an external magnetic field in terms of quantum
mechanics. This description of the magnetic moment is essential to understanding the
basis of MRI, but the use of quantum mechanics is only necessary to this point. While a
single nuclear spin is governed by these properties, a large ensemble of these spins may
be accurately described by classical mechanics. In a typical imaging voxel within an MRI
experiment, the number of individual water protons, or spins, is on the order of 1019. The
use of quantum mechanics is not only unnecessary when dealing with the scales of MRI,
it becomes impractical. This allows the departure from the rigorous quantum mechanical
description of single particle spins, into the classical realm of an ensemble of these spins
OO⃗.
known as bulk magnetization, 𝑀

1.4.3

Spin and the Magnetic Moment II – Classical Description

With the quantum mechanical description of spins in an external magnetic field
described, we now move to a more relevant discussion in MRI imaging: Bulk
OO⃗). 𝑀
OO⃗ is simply defined as the total magnetic moment of an ensemble of
Magnetization (𝑀
N spins such that:
'

OO⃗ = U 𝜇
𝑀
OOO⃗&
()*

(11)
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As discussed earlier, individual spins in an external magnetic field may take on one of
two measured states: spin up or spin down, with the spin up state being the lower energy
state. The population distribution of these states takes on the form of the Boltzmann
distribution:
𝑁↑
𝛾ℏ𝐵%
= 𝑒 !∆.⁄/0 ≈ 1 +
𝑁↓
𝐾𝑇

(12)

Here 𝐾 = 1.38 x 1023 J/K is the Boltzmann constant and ∆𝐸 is the energy difference
between the spin up and spin down states known as the Zeeman energy:
∆𝐸 = 𝐸↓ − 𝐸↑ = 𝛾ℏ𝐵%

(13)

Noting M will simply be the difference of magnetization resulting from spin-up magnetic
moments and spin-down magnetic moments, we arrive at:
OO⃗ ≈
𝑀

𝛾 2 ℏ2 𝑁↓ 𝐵%
𝑧̂
4𝐾𝑇

(14)

Thus, we find that the statistical distribution of an ensemble of spins placed in an external
]3 (𝑡) aligned in the direction of
magnetic field will produce a net magnetization vector 𝑀
O⃗ % = 𝐵
O⃗ % 𝑧̂ . This net magnetization, 𝑀
]3 (𝑡), is said to
the external magnetic field, 𝐵
O⃗ % = 𝐵
O⃗ % 𝑧̂ , according to the following equation
precess about the main magnetic field, 𝐵
of motion, known as the Bloch Equation [78]:
OO⃗(𝑡)
𝑑𝑀
OO⃗(𝑡) × 𝐵
O⃗ (𝑡)
= 𝛾𝑀
𝑑𝑡
This vector may be described by classical mechanics and is no longer quantized into
discrete energy states (ie. it may now take on any orientation in three dimensions). From
this point on all discussions of magnetization refer simply to this bulk magnetization, and
no longer individual magnetic moments.

(15)
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Equation (15) can be rewritten in terms of individual components:
𝑑𝑀3 (𝑡)
=0
𝑑𝑡

(16)

𝑑𝑀4 (𝑡)
= 𝛾𝑀5 (𝑡)𝐵3 (𝑡)
𝑑𝑡

(17)

𝑑𝑀5 (𝑡)
= 𝛾𝑀4 (𝑡)𝐵3 (𝑡)
𝑑𝑡

(18)

The solutions to these equations become:
𝑀3 (𝑡) = 𝐶

(19)

𝑀5 (𝑡) = 𝑀4 cos(𝜔t) + 𝑀5 sin(𝜔t)

(20)

𝑀5 (𝑡) = 𝑀5 cos(𝜔t) − 𝑀4 sin(𝜔t)

(21)

Where C is a constant. In other words, in the presence of an external magnetic field,
O⃗ % = 𝐵
O⃗ % 𝑧̂ , the longitudinal component of the magnetization (Mz) is simply constant
𝐵
while the transverse components (Mx and My) vary sinusoidally around the main
magnetic field.

1.4.4

The Bloch Experiments

The Bloch equations derive their name from Felix Bloch who’s experiments represented
a landmark in NMR and MRI development [79]. Bloch and his colleagues were able to
detect the transverse component of the signal by placing a receiver coil such that
magnetic flux through the coil was at a right angle to the main magnetic field (Bz) and
measuring the small electrical current generated in this coil. Additionally, Bloch et al.
followed this experiment by perturbing the magnetization with a second constant
magnetic field (B1) at right angles to the main magnetic field. He found that this caused a
transient measurable electrical signal in the receiver coil, that decayed at a rate specific to
the individual material being studied. It was reasoned that the individual spin magnetic
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moments were interacting with each other and with their environment, causing the system
to release energy in a process termed relaxation.

1.4.5

Relaxation Time Constants

Felix Bloch defined two relaxation time constants; the spin-lattice and spin-spin
relaxation time constants. These are denoted 𝑇* and 𝑇2 respectively. 𝑇* describes the rate
at which the longitudinal component (ie 𝑀3 (𝑡)) approaches its equilibrium value of
magnetization 𝑀% , while 𝑇2 describes the rate at which the magnetization component
orthogonal to the main field (ie 𝑀45 (𝑡)) decays. Further to these, a time constant, 𝑇2∗ ,
describes the rate at which the magnetization component orthogonal to the main field
decays including the effect of local inhomogeneities in the main magnetic field. These
time constants are largely dependent on the molecular environment as well as magnetic
field strength and temperature. Inclusion of the relaxation terms above modify equation
(15) such that we have:
OO⃗(𝑡)
𝑑𝑀
OO⃗(𝑡) × 𝐵
O⃗ (𝑡) − 𝑅(𝑀
OO⃗(𝑡) − 𝑀% )
= 𝛾𝑀
𝑑𝑡

(22)

Where 𝑅 is the relaxation matrix represented by:
1h
𝑇2
⎛
⎜ 0
0
⎝

1.4.6

0
1h
𝑇2
0

0
⎞
0 ⎟
1h
𝑇* ⎠

The Bloch equations

O⃗ % = 𝐵
O⃗ % 𝑧̂ with
The behaviour of the bulk magnetization 𝑀 in a static magnetic field 𝐵
relaxation terms can now be described. Equation (22) can be rewritten in terms of
individual components as follows:

(23)
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𝑑𝑀3 (𝑡)
𝑀3 (𝑡) − 𝑀%
= 𝛾l𝑀4 (𝑡)𝐵5 (𝑡) − 𝑀5 (𝑡)𝐵4 (𝑡)m −
𝑑𝑡
𝑇*

(24)

𝑑𝑀4 (𝑡)
𝑀4 (𝑡)
= 𝛾l𝑀5 (𝑡)𝐵3 (𝑡) − 𝑀3 (𝑡)𝐵5 (𝑡)m −
𝑑𝑡
𝑇2

(25)

𝑑𝑀5 (𝑡)
𝑀5 (𝑡)
= 𝛾 [𝑀3 (𝑡)𝐵4 (𝑡) − 𝑀4 (𝑡)𝐵3 (𝑡)] −
𝑑𝑡
𝑇2

(26)

These equations are derived in the cartesian coordinate system, or what is commonly
referred to as the “laboratory reference frame”. It turns out that since the magnetization is
constantly precessing at the Larmor frequency in the transverse plane, defining a
“rotating reference frame” simplifies the required mathematics. Replacing 𝐵3 (𝑡) by
𝐵3_899 (𝑡) = 𝐵3 (𝑡) + Ω⁄𝛾, where Ω is the angular frequency of the rotating frame, we
transform the above magnetization equations into the rotating reference frame:
𝑑𝑀3 (𝑡)
𝑀3 (𝑡) − 𝑀%
= 𝛾l𝑀4 (𝑡)𝐵5: (𝑡) − 𝑀5 (𝑡)𝐵4: (𝑡)m −
𝑑𝑡
𝑇*

(27)

𝑑𝑀4 (𝑡)
𝑀4 (𝑡)
= − 𝐵3_899 (𝑡)𝑀5 (𝑡) − 𝛾𝑀3 (𝑡)𝐵5: (𝑡) −
𝑑𝑡
𝑇2

(28)

𝑑𝑀5 (𝑡)
𝑀5 (𝑡)
= − 𝛾𝑀3 (𝑡)𝐵4: (𝑡) + 𝐵3_899 (𝑡)𝑀4 (𝑡) −
𝑑𝑡
𝑇2

(29)

Note 𝐵: refers to the components of the magnetic field defined in the rotating reference
frame. For the remainder of this chapter all equations and derivations will occur in this
rotating frame unless explicitly stated otherwise.

1.4.7

RF Pulses

Up to this point we have discussed magnetic moments, bulk magnetization, and their
behaviour in the presence of a static magnetic field. But how does this lead to an MR
signal? To generate a usable signal, we must manipulate the magnetization using specific
radiofrequency (RF) pulses. These, radiofrequency pulses can cause the magnetization to
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be “rotated” into the transverse plane where, due to Faraday’s Law, can then induce a
measurable signal in a nearby coil.
While there are countless different RF pulse types used in NMR and MRI, we will
illustrate the simplest example of the effect of a single sinc RF pulse that has a duration
much less than that of 𝑇* and 𝑇2 . If this RF pulse is applied along the x axis in the
rotating frame equations ((27 - (29) now become:
𝑑𝑀3 (𝑡)
= − 𝑀5 (𝑡)𝛾𝐵4: (𝑡)
𝑑𝑡

(30)

𝑑𝑀4 (𝑡)
=0
𝑑𝑡

(31)

𝑑𝑀5 (𝑡)
= − 𝑀3 (𝑡)𝛾𝐵4: (𝑡)
𝑑𝑡

(32)

The solutions to these equations are given by:
𝑀3 (𝑡) = 𝑀% cos(𝜔4 t)

(33)

𝑀4 (𝑡) = 0

(34)

𝑀5 (𝑡) = 𝑀% sin(𝜔4 t)

(35)

Where the 𝜔4 represents the frequency of rotation about the x-axis. If we denote 𝛼 = 𝜔4 t
we may generate a general matrix form for the magnetization in all three dimensions
generated by an RF-pulse directed along the x-axis in our rotating frame:
𝑀4 (𝑡)
1
0
r𝑀5 (𝑡)s = t0 cos (𝛼)
0 sin (𝛼)
𝑀3 (𝑡)

0
0
−sin (𝛼) u t 0 u
−cos (𝛼) 𝑀%

Thus when 𝛼 = 90°, 𝑀4 (𝑡) = 0, 𝑀3 (𝑡) = 0, and 𝑀5 (𝑡) = 𝑀% . While this is an
extremely simplistic example, it helps to illustrate the potential to manipulate the bulk
magnetization of an ensemble of spins placed in an external magnetic field.

(36)

16

1.4.8

Signal Detection

According to Faraday’s Law of induction, a time varying magnetic field will generate a
current in a surrounding wire. This is the basis of all NMR and MRI signals. Similar to
the original Bloch experiment, receiver coils are placed such that the magnetic flux
through the coil is at a right angle to the main magnetic field (Bz). As the magnetization
vector is rotated from the longitudinal to the transverse plane and subsequently relaxes,
the magnetic flux through the coil changes and we can measure the current induced. For a
given magnetic field in the laboratory frame:
(37)
OΦ
O⃗; =

O⃗ (𝑟⃗) ∙ 𝑀
OO⃗ (𝑟⃗, 𝑡)𝑑𝑟⃗
𝐵

y
<=(> @:8@

where Φ; is the magnetic flux through the coil, 𝐵(𝑟) is the magnetic field in the
laboratory frame and 𝑀(𝑟, 𝑡) is the bulk magnetization vector. The voltage generated
from this process is
𝑉(𝑡) =

−𝑑Φ;
𝑑𝑡

(38)

Thus, we can see how perturbing the magnetization vector induces a measurable
electrical signal in the surrounding receiver coils.

1.4.9

FID

Once the magnetization has been rotated into the transverse plane due to excitation from
an RF pulse, this magnetization may now be detected due to the voltage it produces in the
receiver coil as described above. In most MR experiments the signal will take a form of a
free induction decay (FID) described by:
(39)
𝑠(𝑡) =

y
<=(> @:8@

OO⃗45 (𝑟⃗, 𝑡)𝑒 !(A(:⃗,E) 𝑑𝑟⃗
𝑀
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where 𝑀45 is the transverse magnetization, r is the vector in Cartesian space, and 𝜔(𝑟, 𝑡)
is the frequency in our rotating frame.

1.4.10

Spatial Localization I – Slice Selection

We have shown how to manipulate the bulk magnetization to produce a measurable
electrical signal by using RF pulses. The next step is to spatially encode the bulk
magnetization to generate a usable image. This is accomplished using additional
magnetic fields, known as gradients, to vary the z-component of the magnetic field
strength along the different axes. Mathematically these gradients are defined as:
𝐺3 =

𝜕𝐵3
𝜕𝐵3
𝜕𝐵3
, 𝐺4 =
, 𝐺5 =
𝜕𝑧
𝜕𝑥
𝜕𝑦

(40)

Of particular importance is the effect the gradient has on the spins at a given position.
Applying a gradient will increase or decrease the total magnetic field strength at a
particular position within the laboratory frame according to the following equation:
𝐵(𝑖) = 𝐵% + 𝑖 ∙ 𝐺(

(41)

where 𝑖 is either the x, y, or z dimension in scanner space. This change in magnetic field
strength alters the Larmor frequency with the new frequency being spatially defined
according to the position relative to the gradient:
𝑓(𝑖) =

𝛾
(𝐵 + 𝑖𝐺( )
2𝜋 %

This allows the selective excitation of nuclei using band limited RF pulses. For example,
if we apply the gradient described above, the Larmor frequency varies linearly along an
axis (usually 𝑧̂ ). Therefore, we may “tune” our RF pulse such that we specifically excite
certain slabs, known as slices, along the length of the longitudinal axis. Using carefully
designed pulse sequences, the user may control the position, shape, and width of each
slice.

(42)
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1.4.11

Spatial Localization II – In-plane localization

In-plane localization relies on two distinct gradients referred to as the phase-encoding
gradient and the frequency-encoding gradient. These gradients induce a temporary
change in the resonant frequencies of excited nuclei that in turn causes a phase shift in the
rotating reference frame given by:
∅ = −𝛾𝐺𝑡
We apply this principle in two dimensions after our slice selective excitation, allowing us
to localize our signal within a slice.
First, in our “phase encode” direction a gradient is applied perpendicular to our main
magnetic field causing a spatially dependent increase in the precessional frequency of the
nuclei along the phase encode axis (Time A in Figure 1.2 below). After the gradient is
removed (Time B), the nuclei return to their initial frequency but with various phase
shifts, dependent on their position along the phase encode axis. In Figure 1.2 the phase
encode axis has been depicted to be the y-axis in the rotating frame and the gradient
strength is represented vertically. These nuclei are now said to be “phase encoded” and
will maintain this phase shift until further gradients are applied or the MR signal decays.
This process is repeated for varied phase encode gradient strengths to sample as many
possible spatial frequencies within a given image.

(43)
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Figure 1.2 - Illustration of phase encoding for spatial localization in the MR signal. At
time A the phase encode gradient is applied leading to attenuation of the precessional
frequency of the spins. Once the gradient is removed (time B), the spins return to their
original frequency but with a spatially dependent phase shift. Thus, these spins are now
phase encoded. Figure reproduced with permission from Picture to Proton.
Finally, we apply a frequency encode gradient, perpendicular to the phase encode
gradient. During the measurement of our signal the frequency encode gradient causes an
accumulated phase shift dependent on the nuclei position on the frequency encode axis.
This gradient is often referred to as our “readout gradient” as it is applied during the
acquisition of our signal. If we sample our received complex signal in quadrature at
discrete time intervals, we can recover both this phase and frequency. Thus, each data
point represents a different “amount” of frequency encoding and corresponds to a
different spatial frequency. By sampling this way, we can collect all the spatial
frequencies in the frequency encode direction with a single RF excitation.
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1.4.12

Fourier Transform and K-space

When we measure the signal from our sample, we obtain a sinusoidal combination of all
the sampled spatial frequencies over the course of a given excitation. By Fourier theory
this signal can be decomposed into individual parts each representing a unique spatial
frequency. We store this information in k-space. k-space is simply our raw data space
where each data point represents a unique spatial frequency and the magnitude
(brightness) of the point represents the relative contribution of that spatial frequency of
nuclei to the resulting image.

Figure 1.3 – Illustration of the k-space trajectory produced by the combination of phase
encoding and frequency encoding used for spatial localization in MRI. Figure
reproduced with permission from Picture to Proton.
Figure 1.3 shows how our phase encode (GPE) and frequency encode (GFE) gradients
allow us to “traverse” k-space. Immediately after our excitation RF pulse, we begin at the
center of k-space (Point A), which represents the total signal irrespective of location.
Generally, we store the signal in 2-dimensional Fourier space, where the axes (kPE, and
kFE) represent the spatial frequencies in the phase encode and frequency encode
directions of the image. We first move to a position along our kPE by applying a phase
encode gradient, and then sample along this line varying our position on the kFE axis
through application of a frequency encode gradient (from points B-D). This process is
repeated for a set number of phase-encode steps to “fill” k-space. From k-space one may
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apply a Fourier transform to reconstruct the k-space data back into a recognizable image
as shown in Figure 1.4.

A

B

Figure 1.4 - A) Representation of the combination of all spatial frequencies obtained
from a given MR signal in k-space. B) MR image reconstructed by Fourier transform
from the shown k-space data. Image reproduced courtesy of Allen D. Elster,
MRIquestions.com.

1.4.13

Spin Echo Pulse Sequence

While there are countless pulse sequences and variations of pulse sequences, most pulse
sequences fall into two categories; spin echo or gradient echo pulse sequences. To
illustrate these pulse sequences, we use pulse sequence diagrams. On the vertical axis we
represent gradient or signal strength and the horizontal axis represents time. In a spin
echo pulse sequence (also known as Hahn Spin Echo [80]), two pulses are used,
commonly a 90° excitation pulse followed by a 180° refocusing pulse. The first pulse tips
the magnetization into the transverse plane (also known as excitation). Once in the
transverse plane the individual spins tend to precess at different rates due to magnetic
field inhomogeneities. By applying a 180° refocusing pulse those spins that precess faster
will be reordered and are now behind. At some time, known as the Echo Time (TE), these
spins will eventually catch up, forming a coherent signal known as an echo. We will find
later that this pulse sequence is the backbone of the NODDI pulse sequence used in this
thesis.
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Figure 1.5 – Representative spin echo pulse sequence diagram. In the spin echo pulse
sequence, a 180° refocusing pulse is used to invert the spins in the transverse plan,
leading to rephasing known as an echo.

1.4.14

Gradient Echo Pulse Sequence

In a gradient pulse sequence, we apply a dephasing gradient along the frequency encode
axis to speed up the dephasing of the spins in the transverse plane. To create a
measurable echo, we then apply a gradient of opposite polarity and equal magnitude
(termed a rephasing gradient), causing the spins to rephase and create our echo. By
applying these gradients, we may speed up the formation of our echo as opposed to the
spin echo pulse sequence, and thus gradient echo sequences form the basis of many rapid
imaging techniques [81].
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Figure 1.6 – Representative gradient echo pulse sequence diagram. In the gradient echo
pulse sequence, a dephasing and rephasing gradient of equal and opposite polarity is
used to rapidly create an echo in our signal.

1.5 Diffusion and MRI
To this point, we have briefly described how an image is generated by manipulating
protons of the water molecule with various magnetic fields and RF pulses. In this section
we show how we may further manipulate the MR signal to measure how water moves
within biological tissue. By doing this we are able infer various microstructural
components of the brain and gain greater insight into the structural basis of brain
function. In this section, a brief background of diffusion in biological tissues will first be
introduced followed by the technical aspects and implementation of diffusion weighted
MRI (dMRI).

1.5.1

Introduction to Diffusion and Diffusion Weighted MRI (dMRI)

This section will cover the basics of diffusion in a biological context. Much like relating
the quantum mechanical description of magnetic moment to the bulk magnetization, we
begin by giving a brief description of the microscopic properties of diffusion. However,
within the context of MRI, the diffusion of water in tissue can be adequately explained on
the macroscopic level and the need for the complex mathematics associated with
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microscopic diffusion can be largely ignored. First the phenomenon of diffusion will be
discussed and then diffusion will be related to the previous discussion of MRI to show
how to produce image contrast related to diffusion in a biological medium.

1.5.2

The Microscopic Description of Diffusion – Brownian Motion

Diffusion by definition is the motion of molecules in a random pattern due to thermal
motion. This process is also known as Brownian motion, named after Robert Brown, who
published his observations in an 1827 paper of the apparently random motion of pollen
grains immersed in a fluid medium [82]. While Brown discussed these observations, the
exact mathematical description of these interactions may not be solved analytically.
Similar to the previous description of spins in a magnetic field, when discussing
ensembles of particles in a fluid medium, statistical methods can be used to bridge the
gap from the microscopic to the macroscopic and provide a mathematical solution to
macroscopic diffusion.

1.5.3

Macroscopic Diffusion in an Isotropic Environment

In 1855, Adolf Fick began to describe the phenomenon of diffusion, on a macroscopic
scale, based on the concepts of flux and concentration gradients [83]. His first law states
that particle flux 𝐽, in an isotropic fluid medium, will be directed from areas of high
concentration to low concentration and will be proportional to the concentration of
particles in the medium at a given point in space. Mathematically stated:
O⃗𝑛(𝑟, 𝑡)
𝐽⃗ = −𝐷∇

(44)

Here 𝑛(𝑟, 𝑡) is the concentration of particle at position r and time t and 𝐷 is simply a
scalar value describing the rate of diffusion in the given medium. As the medium is
isotropic, 𝐷 is the same in all directions. Fick’s second law uses conservation of mass to
predict how diffusion will lead to concentration changes over time giving:
𝜕𝑛
= 𝐷∇2 𝑛
𝜕𝑡

(45)
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Here concentration changes (𝜕𝑛⁄𝜕𝑡) within a volume are proportional to the second
O⃗2 𝑛) and the diffusivity (𝐷).
derivative of the concentration gradient (∇
In 1905, Einstein described the observations made by Brown and Fick, using the random
walk model (ie. a stochastic process) [84] leading to a mathematical framework to
describe Brownian Motion. In this model, a path is described as a series of successive
steps on a Cartesian grid and a step is defined as a move from one grid point to another
and each possible step is weighted with equal probability. For example, in Figure 1.7 A)
below, a two-dimensional random walk model is shown where each possible step has
probability p = 1/4. As the number of steps grows, the end points for each successive run
tends towards a Gaussian distribution. This is known as isotropic diffusion and the
probability of finding a particle at a given point in space and time can be solved
mathematically. This same situation is further shown Figure 1.7 B) in three dimensions
where each step has probability p=1/8 (cube).
Consider first an ensemble of particles in an isotropic medium. The probability density
𝑃(𝑅O⃗, 𝑡), that a particle will move distance, 𝑅O⃗, in some time, 𝑡, can be computed by
solving:
𝜕𝑃(𝑅O⃗, 𝑡)
= 𝐷∇2 𝑃(𝑅O⃗, 𝑡)
𝜕𝑡

(46)

The solution to this equation, commonly now known as the ensemble average propagator
(EAP) or diffusion propagator, is simply a Gaussian distribution [84]:
!

I⃗ G
GH
1
!
#JE
𝑃(𝑅O⃗, 𝑡) =
𝑒
(4𝜋𝐷𝑡)"⁄2

where 𝐷 is the diffusion coefficient, D represents a measure of the squared particle
displacement over time. In the isotropic medium described here, the diffusion coefficient
is independent of direction, which is the definition of isotropic diffusion.
In the biological context the diffusion coefficient is experimentally determined and based
on the mass of the molecule and the temperature and viscosity of the medium. For water

(47)
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molecules diffusing in water at 37°C, the diffusion coefficient has been determined to be
3x10-9m2/s2 [87]. Therefore in 50 ms, approximately 32% of the water molecules will
have moved 17 μm. whereas only 5% of them have travelled over distances greater than
34 μm. [88].

Figure 1.7 – Illustration of a random walk in A) 2-dimensions and B) 3-dimensions. In
each image a single particle was allowed to diffuse freely according to the random walk
model with n=100 steps and A) p=1/4 from the origin or B) p=1/8. The resulting point
clouds show the endpoints for the diffusion of a particle after 1000 successive trials
tending toward Gaussian isotropic diffusion. Reproduced with permission of Frank R.
Lawrence from The Principles of Diffusion Tensor Imaging [77].

1.5.4

Macroscopic Diffusion in an Anisotropic Environment

In the previous illustration, diffusion was in a purely isotropic medium, with no barriers
present. This situation is rarely found in a biological medium, as barriers are generally
present and rarely are there purely homogenous environments. Examples of barriers
relevant to diffusion imaging include cell membranes and axonal fibres due to the
associated timescales of the diffusion measurement (which we will find later to be
approximately 50-100 ms and will be discussed in 4.7) [89]. When such barriers are
present, diffusion will predominantly occur in a direction perpendicular to the barrier.
Einstein’s relation may be extended in these cases to describe the directional variations in
diffusion by:
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𝐷44
𝐷 = r𝐷54
𝐷34

𝐷45
𝐷55
𝐷35

𝐷43
𝐷53 s
𝐷33

𝐷 is now defined by the diffusion tensor, representing anisotropic diffusion. This tensor
is a positive definite, symmetric (𝐷0 = 𝐷) tensor. Otherwise stated this tensor allows us
to mathematically describe diffusion with directional dependence, known as anisotropic
diffusion.

Figure 1.8 - Illustration of a random walk with hypothetical barriers present in A) 2dimensions and B) 3-dimensions. In each image a single particle was allowed to diffuse
freely according to the random walk model with n=100 steps and A) p=1/4 from the
origin or B) p=1/8. The resulting point clouds show the endpoints for the diffusion of a
particle after 1000 successive trials tending towards anisotropic diffusion. Reproduced
with permission of Frank R. Lawrence from The Principles of Diffusion Tensor Imaging
[77].

1.5.5

Diffusion NMR and the Bloch-Torrey Equations

Until now, the phenomenon of diffusion has not been related to the diffusion
measurement made by MRI. The Bloch equations described earlier do not account for
the effects of the diffusion of water on the magnetization vector, and consequently do not
provide a basis for the measurement of water diffusion in tissue by MRI. Early
experiments in NMR provided the basis for diffusion weighted MRI. In 1956, H.C.
Torrey accounted for the effects of diffusion in an NMR experiment, producing what is
known as the Bloch-Torrey equation [90]:

(48)
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OO⃗
𝑀 𝚤⃗ + 𝑀5 𝚥⃗ (𝑀3 − 𝑀% )𝚤⃗
𝑑𝑀
OO⃗ × 𝛾𝐵899 − 4
O⃗ ∙ (𝐷∇
O⃗𝑀
OO⃗)
=𝑀
−
+∇
𝑑𝑡
𝑇2
𝑇*

(49)

This equation describes the time evolution of the transverse magnetic field incorporating
the effect of diffusion of water in a biological medium.

1.5.6

Stejskal-Tanner: The PGSE and b-value

In 1965 Stejskal and Tanner introduced the Pulsed Gradient Spin Echo (PGSE) sequence
to measure the diffusion coefficient D [91]. The sequence is diagrammed in Figure 1.9
and based on the spin echo pulse sequence described previously. Important to note are
two quantities unique to the PGSE and essential for diffusion measurements: 𝛿, the
diffusion gradient duration and ∆, the duration between the two diffusion gradients. In
this pulse sequence, two diffusion gradients are placed symmetrically on either side of the
180° refocusing pulse. The phase change induced by the first gradient will be:
∅* = −𝛾(𝛿𝐺)𝑥*

(50)

where 𝑥* indicates the position of the particle as the diffusion gradient is applied and 𝐺 is
simply the gradient strength. The phase change during the second pulse is:
∅2 = −𝛾(𝛿𝐺)𝑥2
where 𝑥2 is the new position of the particle.

(51)
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Figure 1.9 – Representative pulse sequence diagram for the PGSE sequence when no
diffusion is present (A) and when the spins diffuse (B). Here 𝜹 is the diffusion pulse
duration and ∆ is the duration between the two diffusion pulses. When no diffusion is
present, the diffusion gradients act equally and opposite on either side of the refocusing
pulse and all spins rephase to create a full echo. When diffusion is present, the diffusion
gradients have unequal effects on either side of the refocusing pulse, thus leading to a
reduced echo.
If a particle has not moved (ie. no diffusion has taken place), the phase changes caused by
the two diffusion gradients will cancel resulting in no signal attenuation. Stejskal and
Tanner showed that if a particle moved during or between the diffusion gradients, the
magnetization, and therefore the signal 𝑆(𝑟), would be attenuated giving:
𝑆(𝑟) = 𝑆% (𝑟)𝑒

O
K!L ! |N|! O ! P∆ ! QJR
"

(52)

Commonly in Diffusion Weighted Imaging, several terms above are collected into a
single “b-value”, a term coined by Le Bihan [92]:
𝑏 = 𝛾 2 |𝐺|2 𝛿 2 Œ∆ −

𝛿
•
3

(53)
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This b-value is user defined and indicates the amount of diffusion “weighting” that
attributed to a diffusion imaging pulse sequence. Now Equation (53) reduces to:
𝑆(𝑟) = 𝑆% (𝑟)𝑒 [!TJ]

(54)

Simply put, diffusion of water during the time course of the pulse sequence leads to
measurable signal loss.

1.5.7

Diffusion Timescales

So, what are these pulse sequence timescales and why do these scales uniquely lend
themselves to applications such as neuroimaging? Table 1.1 shows some representative
(but by no means exhaustive) values of axon diameter, cell body diameter, and extra
axonal space (ie space between neighbouring axons) in both rats and humans. We term
these unique areas as microstructural environments. The typical diffusion time in a
diffusion experiment is determined from various pulse sequence parameters and largely
ranges from 20-100 ms [88]. In that time the mean water displacement will range from 1
- 15 µm, which allows for enough diffusion to differentiate between each of the
microstructural environments below. Therefore, over the course of a diffusion pulse
sequence, the signal is weighted by not just diffusion, but the relative contribution of
diffusion within each of these microstructural environments.
Table 1.1 - Representative values of human and rat microstructural features and
diffusion parameters.
Quantity

Humans

Rats

Axon Diameter in Corpus
Collosum

0.5 – 5.0
µm [93]
< 50 µm
[96]
8 µm [99]
(internal
capsule)

0.4 – 3.0 µm
[94,95]
< 15 µm
[97,98]

Neuron Cell Body Diameter
Extra Axonal Space
Diffusion time in DTI

50 - 100 ms [88]

Mean Water Diffusion Distance

1 - 15 µm [100]

not available
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1.5.8

Diffusion-Weighted Imaging (DWI) and the Apparent Diffusion
Coefficient (ADC)

With this in mind, in 1990, Moseley et. al., attempted to describe directional diffusion
[101]. Combined with an “unweighted” image (ie. one lacking any diffusion gradient),
the metric called apparent diffusion coefficient (ADC), may be obtained:
𝑙𝑛 (𝑆(𝑏))
= −𝑏 ∙ 𝐴𝐷𝐶
𝑆%

(55)

By measuring this ADC in multiple directions, a measure of anisotropy may be obtained.
Initially, Moseley et al. proposed a metric based on ADCz/ADCx, requiring two DWI’s
[101]. This method suffered though as it was rotationally variant, and largely depended
on the gradient encoding directions.

1.5.9

Diffusion Tensor Imaging

In an attempt to overcome the rotational variance, in 1994 Basser et al. proposed the use
of the diffusion tensor to characterize the local diffusion within a voxel [102]. The
diffusion tensor is given by:
𝐷44
𝐷 = r𝐷54
𝐷34

𝐷45
𝐷55
𝐷35

𝐷43
𝐷53 s
𝐷33

This is the same tensor used by Einstein to describe Anisotropic Gaussian diffusion.
Thus, this tensor allows us to determine the magnitude and direction of diffusion in three
independent directions within a given imaging voxel.

1.5.10

The Diffusion Tensor (Imaging) Metrics

Commonly there are several scalar metrics one may extract from the diffusion tensor:

(56)
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Trace: The trace provides a metric of the magnitude of the diffusion tensor.
Mathematically the trace is simply the sum of the individual eigenvalues of 𝐷:
𝑇𝑟𝑎𝑐𝑒 (𝐷) = 𝜆* + 𝜆2 + 𝜆"

(57)

Here 𝜆* , 𝜆2 , and 𝜆" represent the principle, secondary and tertiary eigenvalues
respectively.
Mean Diffusivity (MD): MD is a metric indicating the overall magnitude of diffusion, or
simply the average of the eigenvalues of 𝐷:
𝑀𝐷‘𝐷’ =

𝜆* + 𝜆2 + 𝜆"
3

(58)

Axial Diffusivity (MD): For a directionally dependent diffusion tensor, the axial
diffusivity may simply be defined as the magnitude of diffusion along the longitudinal
(principle) axis of the tensor:
𝐴𝐷‘𝐷’ = 𝜆*

(59)

Radial Diffusivity (MD): For a directionally dependent diffusion tensor, the radial
diffusivity is the average diffusion radiating in the transverse directions of the tensor
(secondary and tertiary eigenvalues):
𝑅𝐷‘𝐷’ =

𝜆* + 𝜆2
2

(60)

Fractional Anisotropy (FA) is a metric ranging between 0 and 1 and describes the
degree of directionality of the diffusion tensor. An FA value of 0 indicates purely
isotropic (Gaussian Diffusion) while a value nearing 1 indicates highly directional
diffusion. FA is mathematically determined as:
(𝜆* − 𝜆2 )2 + (𝜆2 − 𝜆" )2 + (𝜆" − 𝜆* )2
𝐹𝐴‘𝐷’ = ”
2(𝜆* 2 + 𝜆* 2 + 𝜆* 2 )

(61)
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Figure 1.10 - Representative depictions of the diffusion tensor as an ellipsoid. A)
Isotropic Gaussian diffusion, l1=l2 =l3; FA = 0 B) l1 >l2 ,l3 , 0 < FA < 1.

1.5.11

Shortcoming of dMRI and DTI

Since its introduction, DTI has largely become the standard for diffusion weighted
imaging protocols. The applications have become widespread, including, but not limited
to, brain injury [103,104] neurodegenerative disease [105,106], behaviour [107] and even
cardiac imaging [108]. Indeed, DTI has become a powerful tool by which researchers
may infer underlying tissue microstructure. Despite this utility, DTI suffers from some
limitations. Each marker obtained provides a localized metric of average water diffusion
from which subsequent analysis relies on inference for a conclusion. Thus, while
powerful, DTI lacks the specificity to identify unique microstructural environments (such
as those listed in 1.5.7). Without this information DTI cannot distinguish between distinct
processes such as loss of structural integrity or neural remodelling, and thus leads to an
inherently vague and limited model of neuroanatomy [109]. To this end, more
sophisticated dMRI acquisition and reconstruction techniques have been developed to
overcome the limitations of DTI one of which is neurite orientation dispersion and
density imaging (NODDI) [29]. From here the focus of this thesis will be on NODDI.
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1.6 Neurite Orientation Dispersion and Density Imaging
The following sections discuss neurite orientation dispersion and density imaging
(NODDI) and how it may offer an improvement over traditional dMRI techniques such
as DTI by reconstructing tissue microstructure directly from the diffusion MR signal. The
equations and metrics derived in this section follow those presented in [29,30]

1.6.1

NODDI Tissue Model

NODDI uses a biophysical tissue model with three separate non-exchanging
microstructural compartments: intra-neurite, extra-neurite and CSF. NODDI
distinguishes between each compartment based on the diffusion characteristics of each of
these distinct environments. The intra-neurite space refers to the space taken up by
dendrites and axons collectively. The diffusion in this space is unique in that it is highly
restricted in any direction perpendicular to the long axon of a neurite, while it is
unhindered in a direction parallel to it. Conversely, within the space surrounding the
neurite, largely comprised of glial cells, cell bodies and in the case of mTBI various
blood borne proteins, diffusion is hindered but much less so than in the intra-neurite
space. Thus, this diffusion may be described as simple anisotropic Gaussian diffusion.
Finally, the CSF or isotropic compartment is simply the space taken up by cerebrospinal
fluid and modeled as isotropic Gaussian diffusion.

1.6.2

NODDI Signal Equation

In this work a PGSE pulse sequence as described in the 1.5.6 is used to generate the
NODDI signal. Based on the three-compartment model described above, the full acquired
signal S is normalized as:
𝑆 = 𝑣(V= 𝑆(V= + (1 − 𝑣(V= )(𝑣(W 𝑆(W + (1 − 𝑣(W )𝑆8W )
Here, 𝑆W is the signal belonging to each characteristic microstructural compartment, and
𝑣W is the volume fraction of water belonging to each characteristic microstructural
compartment. Here 𝑖𝑠𝑜, 𝑖𝑛, and 𝑒𝑛 indicate the isotropic, intra-neurite and extra-neurite
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compartments respectively. Each compartment has a characteristic signal component that
may be described individually.
First, the signal from the isotropic compartment is separated from the full signal equation
(ie. CSF compartment). This is simply modelled as signal decay due to isotropic diffusion
with diffusivity 𝑑(V= :
𝑆(V= = 𝑒 !TX"#$

(63)

The intra-neurite component 𝑆(W is defined as a set of “sticks” of zero radius and parallel
diffusivity 𝑑∥ distributed in space according to the Watson distribution and
mathematically defined as:
!

𝑆(W = y 𝑓(𝑛O⃗)𝑒 !TX∥ (ZI⃗∙WI⃗) 𝑑𝑛O⃗

(64)

\!

!

Here 𝑒 !TX∥ (ZI⃗∙WI⃗) describes signal attenuation due to a given b-value, 𝑏, gradient direction,
𝑞⃗, and diffusion direction, 𝑛O⃗, while 𝑓(𝑛O⃗)𝑑𝑛O⃗ is the probability of a given neurite having an
orientation within 𝑑𝑛O⃗, an infinitely small cone centered around 𝑛O⃗ ∈ 𝑆 2 → ℝ] . Following
the work of Zhang et al. [30], the orientation distribution function, 𝑓(𝑛O⃗), follows a
Watson distribution:
!*
1 3
!
𝑓(𝑛O⃗) = 𝑀 Œ , , 𝜅• 𝑒 ^(_I⃗∙WI⃗)
2 2

(65)

Here M is a confluent hypergeometric function, 𝜇⃗, is the mean orientation and 𝜅 is the
concentration parameter that quantifies the orientation dispersion about 𝜇⃗.
The extra-neurite signal component, 𝑆8W , is modelled as attenuation due to anisotropic
Gaussian diffusion:
𝑆8W = 𝑒 !TZI⃗

& `∫ 9(W
I⃗)J(W
I⃗)XW
I⃗ bZI⃗
'!

Here 𝐷(𝑛O⃗) is a cylindrically symmetric tensor, with parallel diffusivity 𝑑∥ , perpendicular
diffusivity 𝑑c and principle diffusion orientation along 𝑛O⃗. As in [29], the parallel
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diffusivity matches that of the intra-neurite compartment, with the perpendicular
diffusivity set using a tortuosity model [110] as
𝑑c = 𝑑∥ (1 − 𝑣(W )

(67)

The orientation dispersion index (ODI) is defined as a value ranging from 0-1 according
to the concentration parameter of the Watson distribution 𝜅
𝑂𝐷𝐼 =

1.6.3

2
1
𝑎𝑟𝑐𝑡𝑎𝑛( )
𝜋
𝜅

NODDI Fitting

The NODDI fitting routine fixes the diffusivity values 𝑑∥ = 1.7 x 10-3 mm2/s and
𝑑(V= = 3.0 x 10-3 mm2/s. The following parameters are then estimated to solve the above
equations: 𝑣(W , 𝜅, 𝜇⃗, and 𝑣(V= . Briefly, the fitting procedure first follows a brute-force
search over a grid of physically plausible values based on known tissue properties. The
results of this initial search are then used as a starting point for a Gauss-Newton nonlinear
optimization procedure, using a Rician noise model, to produce the maximum likelihood
estimates of the parameters listed above.

1.6.4

NODDI Acquisition

The NODDI acquisition scheme relies on a multi-shell acquisition scheme. Multi-shell
refers to the use of multiple b-values and offers distinct advantages to the single shell
acquisition (single b-value) employed in DTI. Higher b-value ( > 1000 s/mm2) images
have been shown to increase contrast between gray matter and white matter and better
elucidate the smaller microstructural features in white matter but suffer from low signal
to noise ratio [111–113]. Lower b‐value images ( < 1000 s/mm2) on the other hand
provide a higher signal‐to‐noise ratio (SNR) and more anatomic information [114]. By
using multiple b-values, we are able to gain both advantages and encode more detailed
features of the cellular environment within our dMRI signal, with the caveat of increased
acquisition time [115,116]. In 2012, Zhang et. al. provided the seminal work for the
optimization of the NODDI acquisition [29]. It was shown for NODDI metrics to be
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accurate and precise with only two moderate non-zero b-values. In simulation the optimal
choice of these b-values to be 711 s/mm2 and 2855 s/mm2 but in-vivo the precise choice
of these b-values had little effect on the resulting NODDI metrics. Finally it was also
shown that the precise distribution of directions of b-values within and between shells
had limited effect on the resulting parameters provided sufficient angular resolution was
achieved (while sufficient was not expressly quantified within this paper, by convention
it is taken to be a HARDI [117] acquisition with > 50 total gradient directions). While
this study was performed in humans, it also showed quantitatively that all microstructural
parameters were minimally affected by axon diameter lending this application to nonhuman models.

1.6.5

NODDI Metrics

From the above signal equations, the following scalar metrics may be obtained:
Neurite Density Index (NDI): Neurite density Index is a scalar value ranging from 0 to
1 and represents the volume fraction of the diffusion signal originating from within the
axons and dendrites.
Orientation Dispersion Index (ODI): Orientation dispersion index is a scalar value
ranging from 0 to 1 and represents the dispersion of the modelled “sticks” of the intraneurite compartment. A value near 0 represents highly aligned and coherent fiber bundles
(ie white matter tracts of the corpus collosum), while a value towards one represents
widely dispersed fibers (ie grey matter).
Extra-Neurite Volume Fraction: The extra-neurite fraction represents the volume
fraction of the diffusion signal originating from anisotropic gaussian diffusion. This
would be indicative of diffusion near neurons and axons and within cell bodies. This is a
simple 1-NDI, and thus varies inversely with NDI as a scalar value.
Isotropic Volume Fraction (IsoVF): Isotropic volume fraction is a scalar value from 0-1
and represents the signal originating from freely diffusing water. Within the nervous
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system, this can largely be attributed exclusively to the CSF, but may also arise from
pathological processes such as Edema.

Figure 1.11 - Representation of the relevant NODDI metrics obtained from a multi-shell
PGSE signal within a given imaging voxel. Notice the diffusion signal may be
simultaneously reconstructed to produce DTI metrics.

1.6.6

NODDI in Traumatic Brain Injury

As discussed in Chapter 2, many neuropathological changes are evident in various stages
of mTBI, of which NODDI may be well situated to detect due to the nature of the multicompartmental biophysical model. Pathological processes such as axonal beading lead to
an increase in NDI as the inner diameter of the axon expands, whereas demyelination
would lead to a decrease in NDI. Separate changes within the extra-neurite compartment
such as neuroinflammatory effects may lead to increased NDI. Thus, NODDI is uniquely
situated to image mTBI in-vivo in an attempt to understand the various pathological
processes taking places in the immediate stages following mTBI.
To this point though, the use of NODDI in traumatic brain injury studies has been
undertaken exclusively in the clinical realm and to our knowledge, limited to a select few
studies. Table 1.2 below summarizes the currently available studies applying NODDI to
brain injuries and the relevant changes in NODDI metrics found in each study with
respect to matched controls.
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Table 1.2 - Summary of the currently published work applying NODDI in traumatic brain
injury and concussion.
Imaging
Study
Study
Time PostNDI
ODI
IsoVF
Participants
Injury
Decrease (left
anterior corona
Increase (left
Athletes with a
radiata.
anterior corona
history of
> 6 months
Splenium of the
radiata and
[118]
concussion
postcorpus
None
proximal to the
(male and
concussion
callosum,
left superior
female)
superior
corona radiata)
longitudinal
fasciculus
Athletes
Decrease
during
1-7 days post- (corona radiata
[119]
concussion
None
None
concussion
and longitudinal
recovery (male
fasciculus)
and female)
Participants
with mTBI due 15 ± 10 days
Decrease
[120]
None
None
to auto p
post-mTBI
(various regions)
accidents.
It can be seen that the study designs and results vary greatly. While these studies suggest
the information provided by NODDI may be valuable in mTBI, such studies are still
limited their ability to relate changes in diffusion to the underlying pathological processes
taking place. Thus, for proper interpretation, we must first evaluate the effect of various
pathophysiological processes on the signal changes detectable by NODDI in a traumatic
brain injury. Pre-clinical rodent imaging provides such an opportunity.

1.6.7

NODDI in Pre-Clinical Rodent Models

In the development of novel techniques and exploration of disease models, pre-clinical
animal models are often used. Mice and rats are often the animals of choice in these
studies, as they share similar genetic information with humans, and in many instances
similar biochemical, physiological, and microstructural properties [121] in the brain.
Combined with their fast reproduction rate, relatively low economic footprint, and
limited variation within breeds, rodent models are ideal to explore many normal and
disease processes within the nervous system [122].
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Although there are advantages to using rodent models, there are also many distinct
disadvantages in regard to MRI. The largest of these is their size. The rat brain is
approximately 500 times smaller than the human brain, presenting many technical
challenges such as limited spatial resolution and low signal-to-noise ratio (SNR)
[123,124]. Compounding these challenges with those specific to measuring the diffusion
of water within and near neurites presents a challenging prospect. Many recent technical
advances in MRI have helped to overcome these challenges including the use of ultrahigh
field magnetic field strength (of particular importance to this thesis). Additionally,
advances in modelling and image reconstruction have furthered the abilities of MRI
within a pre-clinical setting such that the ability to image neurite density directly in-vivo
in a pre-clinical rodent model is becoming a reality.
As described in section 1.2, the overall objective of this work is to develop neurite
orientation dispersion and density imaging into a viable dMRI technique applicable to
detection of subtle microstructural changes in pre-clinical rodent models of early mild
traumatic brain injury at 9.4 Tesla. Additionally, we aim to determine whether NODDI
metrics provided greater sensitivity than standard dMRI metrics to changes in the brain
following mTBI in a rodent model. However, with any novel technique, the feasibility
and reproducibility of the underlying metrics must be evaluated, so that researchers can
confirm or reject a hypothesis with a known level of certainty. Therefore, the objective of
the first experimental work described in this thesis was to quantify the reproducibility of
NODDI in a rodent model at 9.4 Tesla. In addition, various analysis techniques and the
necessary sample sizes and biological effects by which an accurate statistical inference
may be gained were explored.
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Chapter 2

2

Reproducibility of Neurite Orientation Dispersion and Density
Imaging (NODDI) in Rats at 9.4 Tesla
2.1 Introduction
Diffusion weighted magnetic resonance imaging (dMRI) is a powerful magnetic
resonance modality that provides a wealth of information regarding tissue microstructure,
from which structural connectivity and pathological changes within the brain can be
inferred [17,125]. As different microstructures predictably retard diffusion, the apparent
diffusion of molecules combined with the angle of an applied diffusion gradient provides
an indirect measure of neuroanatomy [102]. The most commonly used dMRI technique is
diffusion tensor imaging (DTI). For DTI, a series of pulsed-gradient, spin–echoes are
used to produce a 3x3 symmetric matrix modelling Gaussian diffusion (3). Most
commonly, DTI characterizes the overall water diffusion within a given voxel by
measuring mean diffusivity (MD) and the degree of directionality of the principle
component of this diffusion, through fractional anisotropy (FA). This technique has been
utilized for many years and has provided valuable insights into the effects of disease, as
well as neurological and physiological processes [108,126–129].
However, subtle tissue diffusion characteristics may be missed in DTI because the
method lacks the specificity to identify unique microstructural environments. For
example, DTI cannot distinguish between distinct processes such as the loss of structural
integrity and neural remodelling, and as a result provides an inherently vague and limited
model of neuroanatomy [109,130]. Several more sophisticated dMRI models have been
developed to overcome the limitations of DTI such as Q-Ball imaging [131], CHARMED
[27], diffusion kurtosis imaging [132], oscillating gradient diffusion MRI [133], and more
recently neurite orientation dispersion and density imaging (NODDI) [29]. NODDI
examines neurite morphology by specifically probing the unique diffusion patterns within
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three separate microstructural environments: intra-neurite, extra-neurite, and CSF
compartments [29].
Diffusion patterns within the brain may be separated into three distinct microstructural
environments: highly restricted within neurites (intra neurite compartment), hindered
diffusion near neurites (extra-neurite compartment) and free diffusion within the CSF
compartment [30]. A carefully designed diffusion weighting scheme in an MRI pulse
sequence combined with NODDI modelling is used to produce scalar maps indicating the
volume fraction contribution of each compartment to the full diffusion signal. The intraneurite space is modelled as cylinders of zero radius (modelling highly restricted
diffusion perpendicular to neurites and free diffusion parallel to neural tracts) dispersed
according to the Watson distribution (ranging from heavily dispersed to entirely parallel)
while the extra-neurite space is modelled as Gaussian anisotropic diffusion [134]. Lastly
the CSF compartment is modelled with Gaussian isotropic diffusion [29].
The NODDI acquisition incorporates a multi-shell protocol that leads to a multicompartmental diffusion MR signal. Previous work has shown that the use of 2 shells
(each shell corresponding to a subset of diffusion weightings known as b-values)
combined with several b=0 images, is sufficient to obtain NODDI scalar maps in-vivo
[29]. These images are reconstructed based on the Stejskal-Tanner equations for a pulsed
gradient spin-echo (PGSE) experiment, and the total signal determined to be the sum of
the individual contributions from three non-exchanging tissue compartments (intraneurite, extra-neurite, and CSF compartments) [29]. From this signal, quantitative scalar
image maps may be reconstructed yielding the following NODDI metrics: neurite density
index (NDI), orientation dispersion index (ODI), and isotropic volume fraction (IsoVF).
Additionally, by ensuring one shell conforms to DTI acquisition standards (e.g. a single
shell with > six directions of b = 1000 s/mm2 and one b = 0 volume) [17], it is possible
within a single scan to obtain standard diffusion tensor metrics such as fractional
anisotropy (FA) and mean diffusivity (MD). It is commonly recommended that DTI and
NODDI be acquired simultaneously and analyzed together [109]. While MD and FA are
routine measures obtained in diffusion imaging, the addition of the ODI, NDI, and IsoVF
scalar maps can provide a more specific analysis of complex neuroanatomy [109,130].
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ODI characterizes the angular variation and spatial configuration of neurite structures.
NDI represents the fraction of tissue that comprises axons or dendrites (also referred to as
intra-neurite volume fraction). Extra-neurite fraction may be reconstructed as 1- NDI, and
as such does not provide unique information separate from NDI. IsoVF represents the
CSF water fraction [29].
Previous use of NODDI has focused largely on the feasibility, reproducibility, and
application to human imaging at field strengths up to 3 Tesla [135–141]. Specifically, it
was shown that NODDI metrics were significantly dependent on field strength [142].
Many pre-clinical studies use rodent models to study neuro-pathological processes
requiring extremely small voxel sizes relative to that used in human MRI. Image signal
to noise ratio (SNR) is directly proportional to voxel size and to main magnetic field
strength. Therefore, the use of ultra-high field strengths combined with strong imaging
gradients helps to achieve adequate SNR for diffusion modelling at the image resolution
required in rodent models [143]. While the feasibility of NODDI at 9.4 Tesla has been
shown [144], we are aware of no studies that have explored reproducibility in rodent
models at 9.4 Tesla. As ultra-high field MRI, and specifically pre-clinical rodent MRI,
faces many unique challenges such as increased magnetic field inhomogeneities and
physiological noise [124], it is important to carefully define reproducibility in the context
of ultra-high field rodent imaging. Thus, our specific objective was to determine the
reproducibility of the three most commonly derived NODDI metrics (ODI, NDI and
IsoVF) at 9.4 Tesla in the rat brain. This information is crucial for the planning of future
studies involving rat models of neurodegenerative disease or neurological injury.

2.2 Methods
2.2.1

Subjects

Ten adult male Sprague Dawley rats were scanned twice on separate days with 7 ± 1 days
between scans. Sample sizes were chosen to reflect common practice in pre-clinical
imaging studies. On the day of the scans, anesthesia was initiated by placing the animals
in an induction chamber with 4-5% isoflurane and an oxygen flow rate of 1-
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1.5 L/min. Following induction, isoflurane was maintained between 1.5-2.5% with an
oxygen flow rate of 1-1.5 L/min through a custom-built nose cone. All animal procedures
were approved by the University of Western Ontario Animal Use Subcommittee and
were consistent with guidelines established by the Canadian Council on Animal Care.

2.2.2

Imaging

All images were acquired using a 31 cm bore 9.4 Tesla Agilent small animal MRI
scanner at the Centre for Functional and Metabolic Mapping at the University of Western
Ontario. Images were acquired with an eight-channel receive coil used in conjunction
with a 2-channel transmit coil. The receive coil consisted of eight loops adhered to the
inner surface of a conformal helmet that was adjustable in width to accommodate varying
head sizes. Low input-impedance preamplifiers were used to reduce inter-element
coupling. The transmit coil was comprised of two overlapped rectangular loops mounted
on an inverted U-shaped former. The coil design and optimization followed that built for
marmoset imaging [145], but with dimensions optimized for rat imaging.
The NODDI diffusion encoding scheme was incorporated into a centric-ordered spin
echo echo-planar-imaging (EPI) acquisition pulse sequence (number of shots = 4, number
of averages = 2, 25 slices with slice thickness = 500 µm, FOV 40 x 40 mm, matrix size
160 x 160, resulting in-plane resolution = 250 × 250 µm, TE = 25 ms, TR = 5.0 s). Two
averages were used, rather than increased diffusion directions, to ensure adequate SNR in
the higher b-value shell for NODDI reconstruction. As it is recommended that NODDI be
used in conjunction with standard DTI metrics (FA and MD) [109] we chose a b-value of
1000 s/mm2 for the inner shell. Following the work of Zhang et. al. [29], a second b-value
of 2000 s/mm2 was chosen. Use of these b-values has been shown to produce
reproducible values of NODDI specific metrics in human imaging at lower field
strengths, and can be used to obtain standard DTI measures [29]. To sample q-space, we
chose a scheme totaling 108 directions spread across two b-values, optimized according
to Caruyer et. al. [146]. This sampling scheme allows for twice the number of directions
in the higher b-value shell. Specifically, the outer shell consisted of 72 bvalue = 2000 s/mm2 directions (gradient strength (G) = 339.1 mT/m, time between the
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start of the first and second diffusion pulse (Δ) = 14.44 ms, the duration of a single
gradient pulse (δ) = 4.32 ms, TE = 25 ms and TR = 5.0s). The inner shell consisted of 36
b-value = 1000 s/mm2 directions (G = 169.6 mT/m, Δ = 14.44 ms, δ = 4.32 ms, TE = 25
ms and TR = 5.0s). Fifteen b = 0 s/mm2 were interspersed evenly throughout the
acquisition and two preparation volumes were acquired at the beginning of each average
but not used, resulting in a total imaging time of 83 minutes. A single reverse phase
encoded b=0 volume was acquired at the end of the diffusion sequence for subsequent
use in TOPUP and EDDY (number of shots = 4, number of averages = 2, 25 slices with
slice thickness = 500 µm, FOV 40 x 40 mm, matrix size 160 x 160, resulting in-plane
resolution = 250 × 250 µm, TE = 25 ms, TR = 5.0 s). Anatomical images were also
acquired for each subject within each session using a 3D fast low angle shot [147] pulse
sequence (250-µm isotropic resolution, FOV 40 x 40 x 20 mm, matrix size = 160 x 160 x
50, TE = 5.0 ms, TR = 30.0 ms, total acquisition time = 7 min).

2.2.3

Image Processing

Images were pre-processed using fMRI Software Library (FSL, v.5.0.10, Oxford, UK).
TOPUP [148] followed by EDDY [149] was used to correct for eddy current induced
distortions as well as susceptibility-induced distortions. Brain masks were produced using
the 3D Pulse Coupled Neural Network (PCNN) tool for Matlab [150]. The NODDI
Matlab toolbox (available from the UCL Microstructure Imaging Group) was then used
to produce maps of ODI, NDI, and IsoVF in diffusion space.
For each subject, the first volume in each diffusion data set (b = 0) was aligned with its
corresponding anatomical images using a linear registration in FSL (FLIRT) [151]. The
transformation matrix from the preceding step was then used to bring all NODDI scalar
maps into anatomical space. Anatomical images were then aligned to the Waxholm Space
Atlas Sprague Dawley template [152] using a linear transformation (FLIRT) followed by
a non-linear transformation (FNIRT) [153] in FSL. FNIRT registration parameters were
optimized for the registration of rodent images. While a quantitative analysis (such as
Dice coefficient) of registration quality was not performed, anatomical images were
visually inspected to ensure good registration quality. The Waxholm Space Atlas
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Sprague Dawley template includes binary masks for the relevant brain regions of interest
in this study. Inverse transformation matrices from the preceding steps were used to bring
these masks from template space into the anatomical image space of each rat. Each mask
was eroded by 5% around the edges to avoid partial volume effects within a given ROI.

2.2.4

Statistical Analysis

Statistical analyses to examine measurement reproducibility were performed for the mean
region of interest (ROI) analysis, the whole brain voxel-wise analysis, and the voxel-wise
analysis within a given ROI. These three techniques were chosen as they represent the
most common analysis techniques in neuroimaging studies. The ROI analysis focused on
six different tissue regions: thalamus, corpus callosum, dentate gyrus, hippocampus,
whole brain white matter, and whole brain grey matter. In both the ROI and voxel-wise
analyses the scan-rescan reproducibility was characterized using the coefficient of
variation (CV). CV was chosen as it reflects both the reproducibility and variability of
these metrics as well as provides insight into necessary sample sizes and minimum
detectable effect size. CVs were calculated between subjects and within subjects to
quantify the between subject reproducibility and within subject reproducibility
respectively. The between subject CV was calculated separately for the scan and rescan
conditions as the group standard deviation divided by the mean values from subjects 1-8.
These two CV values were then averaged for the mean between subject’s CV in each
case. The within subject CV was calculated as the standard deviation of the two scans
divided by the mean value. The 8 within subjects CVs were then averaged to determine
the mean within subject CV. Furthermore, the between subject CV was used to determine
the minimum number of subjects needed per group to detect a defined biological effect.
Similarly, the within subject CV was used to calculate the minimum detectable biological
effect with a given number of subjects per group. The details of these calculations follow
those presented in van Belle [154]. The minimum number of subjects and minimum
detectable biological effect were both determined at a 95% significance level (𝛼 = 0.05)
and power of 80% (1 − 𝛽 = 0.80).
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2.3 Results
The minimum accepted average whole-brain SNR was 25 at b=0 for each of the included
data sets. Two data sets were removed from the analysis due to low SNR causing
significant reconstruction bias. Therefore, data were successfully acquired and analyzed
from eight subjects (age 102 ± 13 days at time of initial scan, weight 323 ± 37 g) at two
separate time points. For each subject the re-scan time point was between six and eight
days after the original scan. The time of day was not standardized for the scans. Figure
2.1 shows representative cross sections of raw diffusion data (b=0) from a single subject,
as well as scalar maps of ODI, NDI, and IsoVF.

Figure 2.1 - Representative in-plane cross sections from a single subject showing
unprocessed raw diffusion image data (4 shot, centric ordered, 2 averages, 25 coronal
slices with slice thickness = 500 µm, 250 × 250 µm in plane resolution, FOV 40 x 40
mm, matrix size = 160 x 160, TE = 25 ms, TR = 5.0 s), and corresponding scalar image
maps of the following NODDI values: Orientation Dispersion Index (ODI), Neurite
Density Index (NDI), and Isotropic Volume Fraction (IsoVF).

2.3.1

ROI Analysis

Similar to previous human and rodent studies, higher average ODI values were observed
within grey matter regions compared to that of white matter regions (Figure 2.2) as
expected because neurite orientation is more widely dispersed throughout grey matter
[142,144]. NDI and IsoVF values were similar between white and grey matter. Mean
between and within subject CV for ODI ranged from 4.0-9.2% within all ROIs, NDI
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ranged from 1.9-11.3%, while IsoVF ranged from 9.0-48.6% (Figure 2.3). In general, for
each metric within a given ROI the mean between subject CV was higher than the within
subject CV.

Figure 2.2 – Region of interest (ROI) values for ODI, NDI and IsoVF in both the scan
and rescan conditions for several representative brain regions. Each box represents the
range from 25th to 75th percentile (Interquartile Range) with the median depicted by the
line within the box.

Figure 2.3 - Mean coefficient of variation (CV) for each ROI. Values for the between
subject condition represent the mean ± standard deviation within each ROI averaged
over a scan-rescan protocol. Values for the within subject condition represent the mean ±
standard deviation within each ROI averaged over the eight subjects.

2.3.2

Whole brain voxel-wise analysis

The whole brain voxel-wise analysis showed a similar trend to the ROI analysis in terms
of CVs. In the between subject histogram, over 90% of voxels fell below a CV of 20%
for ODI while in the within subject histogram 90% of voxels fell below a CV of 17%
(Figure 2.4 and Figure 2.5). For NDI over 90% of voxels fell below a CV of 15% and
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12% for the between and within subject histograms respectively. The CV for IsoVF,
ranged well above 100% for many voxels for both histograms.

Figure 2.4 – Whole brain average between subject CV maps and histogram. Values for
the between subject condition represent the mean CV within each voxel for the scan and
rescan conditions averaged over the two scans. The resulting histogram has been
extracted from the averaged scans. Heat maps from a representative slice show the
regional variation for each metric.

Figure 2.5 - Whole brain average within subject CV maps and histogram. Values for the
within subject condition represent the mean CV within each voxel for each subject
averaged over all eight subjects. The resulting histogram has been extracted from the
averaged scans. Heat maps from a representative slice show the regional variation for
each metric.
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2.3.3

Voxel-wise ROI analysis

The voxel-wise approach targeted to specific ROIs (Figure 2.6) reinforced the results
observed in mean ROI and the voxel-wise approaches. For ODI, over 90% of voxels fell
below a CV of 18% in the between subject histogram, and 12% in the within subject
histogram for all ROIs. For NDI, over 90% of voxels fell below a CV of 10% in the
between subject histogram and 8% in the within subject histogram for all ROIs. The CV
for IsoVF once again ranged well above 100% for many voxels in all ROIs. In all cases,
dispersion of CV values increased with increasing ROI sizes. Likewise, in all cases and
all ROIs the CVs and dispersion of CV values were lower within subjects compared to
between subjects.

Figure 2.6 – Voxel-wise between and within subject CV histograms within each
representative ROI. Voxel-wise values for the between subject condition represents the
mean CV within each ROI for both the scan and rescan conditions averaged over the two
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scans. Voxel-wise values for the within subject condition represent the mean CV within
each ROI averaged over the eight subjects.

2.3.4

Sample sizes and minimum detectable effect

Using the between subject whole brain voxel-wise CVs, the minimum number of subjects
was determined on a voxel-by-voxel basis that would allow detection of a statistically
significant change of 5%, 10%, 15% and 20% between subjects in each metric. ODI
produced detectable changes on the order 10% in all voxels for moderate sample sizes (n
< 10) but required large sample sizes (n > 10) for whole brain voxel-wise detection of
changes on the order of 5% (Figure 2.7). NDI was able to detect changes on the order of
5% in all voxels with small sample sizes (n < 6 for all voxels). IsoVF required large
sample sizes (n > 10) to detect changes of any magnitude on a voxel-wise basis.
Using the within subject whole brain voxel-wise CVs, the minimum statistically
significant change that may be detected in each metric on a voxel-wise basis was
determined using a scan re-scan protocol for sample sizes of 6, 8 and 10 within each
group. For over 90% of voxels, ODI was also able to detect small changes (<10%) on a
scan-rescan basis with all sample sizes discussed, NDI showed detection of very small
changes (<5%) with all sample sizes discussed and IsoVF lacked the ability to detect
significant changes at any samples size explored.
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Figure 2.7 – Whole brain voxel-wise histograms representing the i) number of subjects
necessary to detect a statistically significant effect with a change in the given metric of
5%, 10%, 15% and 20% and ii) the minimum detectable effect with each metric under a
scan-rescan study design given group sample sizes of 6, 8 and 10. Note the varied scales
for the IsoVF metric in each category as opposed to the ODI and NDI metrics.

2.4 Discussion
This study examined the reproducibility of the three most commonly derived NODDI
metrics (ODI, NDI, and IsoVF) in the rodent brain at 9.4 Tesla. ODI and NDI were
reproducible, showing low coefficients of variation in both the between and within
subject conditions. CVs were lower within subjects compared to between subjects,
indicating less variability on a within subject scan-rescan basis, as expected. These trends
were observed in the mean ROI, whole brain voxel-wise, and targeted voxel-wise
analyses.
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Using the whole brain coefficients of variation on a voxel-by-voxel basis it was possible
to detect changes on the order of 10% and 5% respectively in ODI and NDI metrics with
feasible study samples sizes. For ODI, over 90% of voxels showed the ability to detect a
10% or greater change with sample sizes of five or more, while NDI showed the ability to
detect a change of 5% or greater with sample sizes of five or more. NDI was the most
sensitive in all cases, followed by ODI. Furthermore, it was shown that using a scanrescan protocol and standard sample sizes (6, 8, and 10) it was possible to detect very
small changes for both ODI and NDI. For example, sample sizes of eight per group
(common to many preclinical studies) allowed biological effects as small as 5% to be
detected on a voxel by voxel basis for both metrics.
While ODI and NDI were shown to be reproducible metrics, IsoVF was not. This was
shown previously in similar studies of the human brain [142]. The IsoVF metric suffers
from not only low values intrinsically in the given context but is also highly susceptible
to noise [142]. This combination led to high average CVs (> 20%) in all measures
explored in this study. Consequently, with the scan parameters used in this study, the
reproducibility of IsoVF is limited. Improvements in SNR could increase the
reproducibility of IsoVF but would come at the cost of increased scan time, decreased
image resolution, or decreased angular resolution. It should be noted that inaccurate
estimates of IsoVF could slightly bias the absolute values of NDI at low SNR, however
this bias is expected to be consistent across all subjects and scans, allowing meaningful
comparisons to be made under consistent scan parameters. As of now the optimal angular
and image resolution in a rodent model of NODDI has yet to be explored, and it must be
assumed that higher resolution in both improves the quality of the resulting scalar metric
maps. Thus, an increase in scan time would be necessary. As the scan time in the present
study was already high (83 minutes) it may be that the necessary scan time to improve the
quality of IsoVF scalar maps is not feasible or cost effective.
These findings are consistent with previous research using human subjects. In humans,
NODDI has been shown to produce accurate and reproducible metrics of ODI and NDI
both between and within subjects [142]. The magnitude of NDI, ODI, and IsoVF have
been shown to vary at different field strengths [142], and thus it is important to
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characterize these metrics not only in new animal models, but also at each field strength
used. At the time of writing we are not aware of any other studies that specifically look at
the reproducibility of NODDI in an in-vivo rodent model. This study shows NODDI to be
reproducible in a rodent model at 9.4 Tesla and that this technique has the potential to
detect very subtle tissue microstructure changes in a rodent model.
There are several limitations that should be considered in this study. Registration was
performed using FLIRT [151] and FNIRT [153] in FSL. The quality of these registrations
was not specifically quantified in terms of similarity overlap. As the quality of
registration is important to both ROI and voxel-wise analyses, future studies may benefit
from improvements and optimization of the registration process. Specifically, when using
a targeted voxel-wise approach within a given ROI, registration can be optimized within
that region, thereby increasing the precision of the analysis. Currently, the optimal
angular resolution, image resolution and b-value combination in our NODDI pulse
sequence has not been fully explored in a rodent model at 9.4 Tesla. It is possible that at
high angular resolution more subtle changes in orientation are detected, and at higher
image resolution more subtle changes in neurite microstructure may be shown.
Furthermore, these parameters may vary greatly in coherently ordered white matter
compared to less ordered structures within regions of grey matter and may be altered in
disease states. These considerations must be balanced against scan time for any in-vivo
study. Further exploration of optimal angular resolution sampling schemes and image
resolution would lend strength to this technique and lead to a more robust acquisition and
analysis pipeline. Additionally, the optimal b-value has not been expressly explored in
rodents at 9.4 Tesla. In humans, the optimal b-values were explored through simulation
and in-vivo study, and it was found that as long as two shells with moderate b-value were
used, the precise choice of b-value made minimal difference [29]. Finally, it should be
noted that for the within-subject calculation of CV, the standard deviation was
determined from only two data points. As a result, this this standard deviation may not
accurately represent the spread of data within the population, leading to an unknown bias
in the resulting CV.
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The current study was designed to evaluate reproducibility of the NODDI metrics over a
one-week interval, as this interval is relevant for many time course studies. While subtle
changes in brain plasticity were of some concern, the results show that over this interval
the ODI and NDI metrics were reproducible. Finally, we know of no studies which have
expressly attempted to produce a template of absolute values of NODDI metrics within
various brain regions of rodents at 9.4 Tesla. While intrinsic variability will always be
present in these values due to scan parameters, it would be useful to attempt this
characterization for all brain regions.
Preclinical imaging techniques, and specifically diffusion imaging techniques, are
designed to detect very subtle changes in disease models, which may not be seen with
anatomical based imaging techniques. The potential to improve the ability to detect these
very small changes through novel neuroimaging techniques, such as NODDI, could
illuminate early events in disease processes such as neurodegeneration. Early detection of
key pathways and mechanisms involved in the progression of these devastating diseases
may lead to a more thorough understanding of the downstream biological effects. By
showing NODDI metrics to be reproducible in a rodent model at ultra-high field
strengths, we may now apply this technique to appropriate pre-clinical models, in an
effort to further our understanding of complex diseases processes affecting
neuroanatomy.
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Chapter 3

3

Neurite Orientation Dispersion and Density Imaging (NODDI)
in a Rodent Model of Early Mild Traumatic Brain Injury
3.1 Introduction
Mild traumatic brain injury (mTBI) is known to result in a range of metabolic,
microstructural, and behavioral effects. The clinical presentation varies greatly and
sometimes unpredictably between subjects and over time and may impair many physical
and cognitive functions [155–158]. Currently there is no pathognomonic test that can be
used to accurately diagnose mTBI, assess the severity, or predict and monitor long-term
outcome. Clinical assessments often rely on subjective measures and patient selfreporting, which are potentially biased, and may limit their utility [45,46]. Furthermore,
Clinical Practice Guidelines (CPGs) regarding appropriate diagnosis and care following a
traumatic brain injury vary widely in quality, comprehensiveness, and implementation
[159–161]. Thus, it is imperative to develop unbiased metrics of mTBI that will allow
informed and accurate diagnosis and lead to more effective patient treatment.
Very little is currently known about changes in the brain within the extremely early
period post mTBI (< 4 hours post-injury). Patients are almost never available during this
early phase for rigorous testing or data collection and thus little MRI data is available for
this initial stage of injury [162]. Often, the severity of the injury is underreported, with
patients only being admitted or cared for if symptoms worsen, once again eliminating the
possibility to obtain clinical data in the very early stages of mTBI [163–165]. However, it
is critical to understand the immediate underlying neurostructural changes that occur in
the brain following injury to place observations at later time points into proper context. It
is has been previously shown that many microstructural and neuroinflammatory changes
occur in mTBI including neuronal cell death, axonal beading, and neuroinflammatory
processes, but these studies have been largely limited to ex-vivo analysis [48,166–169].
Furthermore, several of these studies have indicated that many of these processes can
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occur as early as 30 minutes post-injury, although there is substantial heterogeneity in the
timing, injury model, and animal model used for these studies [56,170–173]. It remains
imperative to develop methods to accurately and reliably assess and monitor the
immediate microstructural and neuroinflammatory processes that occur following mTBI.
Diffusion-weighted MRI (dMRI) is known to be highly sensitive to probing such changes
in brain microstructure and neuroinflammatory processes in-vivo (please refer to
Hutchinson et. al. [174] for an in depth review).
A number of different diffusion MRI approaches may be applied to the study of mTBI,
however neurite orientation dispersion and density imaging (NODDI) provides the most
direct means of assessing neurite integrity. NODDI is a powerful diffusion-weighted
magnetic resonance imaging (dMRI) modality that can probe anatomical microstructure
directly within the brain through careful measurement of water diffusion parameters [29].
NODDI uses a biophysical model by which the total dMRI signal is attributed to the
intra-neurite, extra-neurite and CSF compartments. Each tissue compartment has unique
diffusion characteristics and thus the fraction of signal attributed to each compartment
may be separated and recovered uniquely. In this two-level compartmentalization
approach, the volume fraction of water that diffuses freely (ie. Gaussian diffusion) is
attributed to the CSF space and separated from the total signal. The remaining signal is
compartmentalized into volume fractions of the intra-neurite space, where diffusion is
highly restricted and directional, and the extra-neurite space, where Gaussian diffusion is
hindered. The volume fraction of the intra-neurite space is represented by the metric
neurite density index (NDI) and represents the volume fraction of signal originating from
the dendrites and axons. The signal emanating from the extra-neurite space is
representative of diffusion within cell bodies and near neurons and is simply 1- NDI.
Thus, changes in the volume fraction of water in the intra-neurite and extra-neurite space
are dependent on one another and will vary inversely. In addition to NDI, NODDI
provides an orientation dispersion index (ODI), which characterizes the spatial
configuration of neurites on a range from 0-1, with values near 1 indicating high
dispersion (eg. grey matter), and values near 0 indicating highly coherent organization
(eg. white matter). In addition, using data from the same acquisition it is possible to
obtain the common diffusion tensor imaging (DTI) metrics, such as fractional anisotropy
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(FA), mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity (RD). FA
represents the degree of directionality (as a scalar value from 0-1) and MD represent the
overall amount of diffusion of the diffusion tensor as a whole. AD represents the amount
of diffusion along the primary eigenvector alone and RD represents the average amount
of diffusion along the secondary and tertiary eigenvectors [17].
There have been extensive studies using DTI in both people and pre-clinical animal
models of mTBI, but the results have varied largely and provide little information with
regard to the immediate structural and physiological responses in the brain to this injury
[103]. Previous studies applying NODDI specifically to mTBI have occurred exclusively
in the clinical setting. Churchill et. al. showed an elevated NDI and reduced ODI in
various regions such as the corona radiata and corpus callosum of athletes with a previous
history of concussion (but no reported concussions within 6 months) compared to
controls [118]. In a further study, Churchill et. al. showed that in athletes scanned within
7 days of a diagnosed concussion, NDI was reduced in regions such as the corona radiata
and longitudinal fasciculus, and that these changes persisted beyond the time that athletes
were cleared to return to play [175]. While these studies are informative in clinical
settings, there are currently no studies, either clinical or pre-clinical, that have applied
NODDI to measure microstructural changes during the first few hours following mTBI.
Similarly, we are unaware of any studies using any dMRI technique to examine changes
as early as 1-hour post-injury in a mTBI model. However, in a recent study of mTBI in
rats, mild to moderate changes in group mean FA, MD, and RD were detectable in the
genu of the corpus callosum at 4 hours post-injury (and later timepoints) [176]. In another
study of traumatic axonal injury (TAI) in mice, it was shown that statistically significant
changes in AD, and relative anisotropy (RA) were detected in the corpus callosum by 4-6
hours following injury [21]. While the TAI injury model is far more severe than mTBI,
taken together these studies indicate the presence of microstructural changes detectable
with dMRI as early as 4 hours post-injury.
Given the lack of information regarding immediate brain microstructure changes
following mTBI, the purpose of the current study was to apply NODDI to a rodent model
of mTBI to determine whether microstructural changes in the corpus callosum could be
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detected immediately following injury. Furthermore we investigated potential changes in
the hippocampus as this brain region has been implicated in neurophysiological changes
after various brain injuries [177,178]. Finally, we compared NODDI metrics to standard
DTI metrics to determine if NODDI provided greater sensitivity to early microstructural
changes following mTBI.

3.2 Methods
3.2.1

Subjects

Fifteen adult male Wistar rats (injury: n = 9, age at baseline scan: 123 ± 26 days, weight
at baseline scan: 392 ± 27 g, control: n = 6, age at baseline scan: 131 ± 22 days, weight at
baseline scan: 380 ± 17 g) were acquired from Charles River. Each animal was randomly
assigned to either the control or injury group and was scanned twice: 7 days prior to
injury (Timepoint 1), and from 1 – 4 hours post closed skull controlled cortical impact.
From hours 1-4 post injury, data was collected approximately every 1 hour giving 3
acquisitions sequentially (Timepoints 2 - 4). Please refer to Figure 3.1 for the timeline of
acquisition. All animal procedures were approved by the University of Western Ontario
Animal Use Subcommittee and were consistent with guidelines established by the
Canadian Council on Animal Care.

Figure 3.1 – Timeline of data acquisition for animals randomly assigned to the injury
group which received a single closed skull controlled cortical impact.

3.2.2

Injury

While many different models have been developed to study TBI and mTBI in the preclinical setting, such as the Fluid Percussion Injury (FPI) [179,180] model, the ClosedHead Impact Model of Engineered Rotational Acceleration [181], and Blast TBI model
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[182–184], we chose to use the closed skull controlled cortical impact (CCI) model [185–
188]. CCI is a common and well documented model suited to closed skull mTBI, due to
its close control, reproducibility, and pathophysiological response spectrum that mimics
many important features of mTBI observed in humans [189–192]. It has been well
documented in several animal models including rats and mice [193]. Since it is
advantageous from an imaging perspective to use a larger brain, rats were used for the
current study and the injury model was consistent with previous studies that have used
closed skull controlled cortical impact to induce a mTBI [193–198].
Animals were anaesthetized by induction with 4% isoflurane followed by maintenance
with 2% isoflurane. Each animal was placed in a Kopf mouse anesthesia mask (David
Kopf Instruments, LLC, USA) under a traumatic brain injury device (TBI 0310, Precision
Systems and Instrumentation, LLC, USA). For each impact, the device was programmed
to impact at an intended depth of 3.0 mm, a velocity of 3.5 m/s and a 500-millisecond
dwell time. The impact region for each animal was shaved prior to impact. Each animal
received a single closed skull controlled cortical impact, centered at the sagittal suture,
with a custom-made, 7 mm-diameter, pliant, silicone tip. Following controlled cortical
impact, anesthesia was maintained at 2% isoflurane and using an in-house built portable
induction chamber, each animal was transferred to the small animal MRI facility. Control
animals were anaesthetized 20 minutes prior to their MRI to match the anesthesia time
between induction and scan initiation in impacted animals.

3.2.3

Image Acquisition

Images were acquired using a 9.4T Bruker small animal MRI scanner at the Centre for
Functional and Metabolic Mapping located within the Robarts Research Institute at the
University of Western Ontario. Imaging included the acquisition of high-resolution
anatomical images and NODDI in all animals. Anatomical images were acquired for
each subject at the beginning of each session using a T2-weighted TurboRARE pulse
sequence (8 averages, 32 slices, slice thickness = 500 µm, FOV 32 x 32 mm, matrix size
160 x 160, in-plane resolution = 200 x 200 µm, TE = 44 ms, TR = 7s, echo spacing = 11
ms, rare factor 8, total acquisition time = 14 min)[199]. The NODDI diffusion sequence
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was incorporated into a multi-shot, spin echo, echo-planar-imaging (EPI) acquisition
pulse sequence (4 shots, 32 slices, slice thickness = 500 µm, FOV 40 x 40 mm, matrix
size 160 x 160, in-plane resolution = 250 × 250 µm, TE = 26.71 ms, TR = 2.5 s).
The NODDI diffusion scheme used was previously described in detail and was shown to
produce reproducible and reliable results at 9.4 Tesla [200]. Briefly, a q-space sampling
scheme was used across two-shells, optimized according to Caruyer et. al. [146], with a
total of 90 directions. In shell one, 30 directions with b-value = 1000 s/mm2 were
obtained using the following diffusion gradient parameters: gradient strength
(G) = 172.85 mT/m, time between the start of the first and second diffusion pulse
(Δ) = 14 ms, the duration of a single gradient pulse (δ) = 4.5 ms. In shell two, 60
directions with b-value = 2000 s/mm2 were obtained using the following diffusion
gradient parameters: gradient strength (G) = 345.70 mT/m, time between the start of the
first and second diffusion pulse (Δ) = 14 ms, the duration of a single gradient pulse
(δ) = 4.5 ms. Ten b = 0 s/mm2 scans were interspersed evenly throughout the
acquisition. Four averages were used to ensure adequate signal to noise ratio (SNR) in the
higher b-value shell. The imaging time for each acquisition (four averages) was 66
minutes 36 seconds. A single reverse phase encoded b=0 volume was also acquired prior
to the diffusion sequence for subsequent use in image processing to correct image
distortions.

3.2.4

Image Processing

Brain masks were produced using the 3D Pulse Coupled Neural Network (PCNN) tool
for MATLAB (R2019a) [150]. Raw data were pre-processed using fMRI Software
Library (FSL, v. 6.0.1, Oxford, UK). TOPUP [148] followed by EDDY [149] was used to
correct for eddy current induced distortions as well as susceptibility-induced distortions.
The FDT toolbox (v. 5.0) was used to produce maps of FA, MD, AD, and RD. The
NODDI Matlab toolbox (available from the University College London (UCL)
Microstructure Imaging Group) was then used to produce maps of NDI, ODI, and IsoVF.
All diffusion maps were produced within each subject’s native diffusion image space.
While IsoVF is produced during the processing steps, our previous work has indicated it
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has extremely high variability and low reproducibility with this scan protocol and
therefore we limited our analysis to NDI and ODI only.

3.2.5

Image Registration

For each subject, the first volume in each diffusion data set (b = 0) was aligned with its
corresponding anatomical images using a linear registration in FSL (FLIRT) [151]. The
anatomical image for each subject was then aligned to the Waxholm Space Atlas Sprague
Dawley template [152] using a linear transformation (FLIRT) followed by a non-linear
transformation (FNIRT) [153] in FSL. Binary ROI masks of the corpus collosum and
hippocampus from the Waxholm Space Atlas, were then transformed into the anatomical
space of each individual subject by inverting the preceding non-linear transformations.
Finally, the masks were brought into diffusion space using the inverse transformation
matrix from the b0 image to anatomical image registration. Thus, each mask was brought
into each subject’s individual native diffusion image space. Each mask was then eroded
by a single voxel around the edges to avoid partial volume effects. Masks were visually
inspected to ensure accuracy. For a full description of the processing steps please and
representative binary ROI masks please refer to Supplement.

3.2.6

Statistical Analysis

For each subject, at each timepoint the mean value of each individual scalar metric within
each relevant ROI was extracted using fslstats and the relevant binary mask. A mixed
ANOVA in SPSS [201] was used for each metric to determine if there were statistically
significant interaction effects (p < .05) between controls and injured animals over time.
This test examined whether each metric changed over time and whether those changes
were different between the two groups. Mauchly’s Test was used to determine if the
assumptions of sphericity were violated. In cases where the assumption of sphericity was
rejected, the Greenhouse-Geisser correction was used. In each case where a statistically
significant interaction effect occurred, a follow-up repeated measures ANOVA was run
separately on each group (injured and controlled) to determine if there were statistically
significant changes (p < .05) in the diffusion metric over time within each group.
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Furthermore, post-hoc analysis was used to determine which timepoints differed within
each group (Bonferroni corrected).

3.3 Results
Imaging data were successfully acquired from all 15 animals. Figure 3.2 provides
representative anatomical and corresponding NODDI and DTI scalar maps in a single
animal.

Figure 3.2 – Representative axial single-subject A) raw diffusion image data (b0) and the
following scalar diffusion maps: B) Neurite Density Index (NDI) C) Orientation
Dispersion Index (ODI) D) Isotropic Volume Fraction (IsoVF) E) Fractional Anisotropy
(FA) F) Mean Diffusivity (MD) G) Axial Diffusivity H) Radial Diffusivity . The diffusion
images were acquired with a multi-shell sequence (10 b= 0 s/mm2, 30 b = 1000 s/mm2
and 60 b= 2000 s/mm2) incorporated into a multi-shot, spin echo, echo-planar-imaging
(EPI) acquisition pulse sequence (4 shots, 32 slices, slice thickness = 500 µm, FOV 40 x
40 mm, matrix size 160 x 160, in-plane resolution = 250 × 250 µm, TE = 26.71 ms, TR =
2.5 s).
The exact start and end time of each image varied slightly for each animal: Timepoint 1
(or baseline scan) obtained 7 days prior to injury, Timepoint 2 began at 75 minutes ± 16
minutes post-injury, Timepoint 3 began at 142 ± 17 minutes post-injury, and Timepoint 4
began at 210 ± 17 minutes post-injury.
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3.3.1

Corpus Callosum

Mean ROI metrics in the corpus callosum (Figure 3.3) show a significant increase in the
NDI and ODI immediately after injury that persists to four hours post injury. The first
timepoint after injury showed a 0.046 ± 0.026 (7.83%) increase in average NDI and a
0.051 ± 0.037 (13.7%) increase in average ODI compared to baseline. In contrast, no
changes were observed over time in the control groups. Relevant statistical results are
described in Table 3.1.
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Figure 3.3 - Mean ROI Metrics within the corpus callosum for injured and control
subjects. At each point the mean of the ROI values ± SEM is shown. For NDI and ODI in
the corpus callosum a mixed effects ANOVA in SPSS showed a statistically significant
group by time interaction (p < .05). A repeated measures ANOVA was then used to
determine individual differences amongst the injured and control groups. Post-hoc
pairwise comparisons (Bonferroni corrected) were performed between individual
timepoints within each group. Statistically significant (p < .05) pairwise differences are
indicated by *. Statistical results are listed in Table 3.1 (Mixed ANOVA) and Table 3.2
(Repeated Measures ANOVA).
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Table 3.1 lists the statistical results of the mixed effects ANOVA for both NODDI and
DTI metrics in the corpus callosum. There was a statistically significant (p < .05) group
by time interaction effect for NDI and ODI. There were no statistically significant
interaction effects (p > .05) of group by time for FA, MD, AD and RD.
Table 3.1 – Statistical results of the mixed effects ANOVA for NODDI and DTI metrics
within the corpus callosum. Statistical significance is taken to be p < .05, is denoted with
an asterisk (*) and indicates there is a statistically significant group by time interaction
for that metric within the corpus callosum.
Metric
Statistical Results
NDI

F (3,39) = 6.573

p = .001*

Sphericity Assumed

ODI

F (3,39) = 6.355

p = .011*

Greenhouse-Geisser

FA

F (3,39) = 0.445

p = .722

Sphericity Assumed

MD

F (3,39) = 1.085

p = .345

Greenhouse-Geisser

AD

F (3,39) = 0.166

p = .772

Greenhouse-Geisser

RD

F (3,39) = 1.919

p = .142

Sphericity Assumed

The follow-up univariate analysis of NDI and ODI showed a statistically significant
change over time for the injured group, while no statistically significant change over time
occurred within the control group for these metrics Table 3.2. Statistically significant
changes between individual timepoints within the injury group are depicted in Figure 3.3.
It should be further noted that for every individual subject in the injury group, an increase
occurred in both NDI and ODI from timepoint 1 (Baseline) to timepoint 2 (refer to Figure
3.4). Following this increase, a more heterogenous individual response occurred from
timepoints 2-4, but statistically significant group increases were observed at all three
timepoints post impact.
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Table 3.2 - Statistical results of the follow up univariate ANOVA for NDI and ODI
metrics within the corpus callosum. Statistical significance is taken to be p < .05, is
denoted with an asterisk (*) and indicates there is a statistically significant change in
each metric over time within the given group (Injured or Control).
Metric

Statistical Results

NDI

Injured

F (3,21) = 13.618

p = .001

Greenhouse-Geisser

Control

F (3,9) = 1.318

p = .328

Sphericity Assumed

Injured

F (3,21) = 9.504

p = .000

Sphericity Assumed

Control

F (3,9) = 3.431

p = .066

Sphericity Assumed

ODI

Figure 3.4 - Mean ROI values of NDI and ODI within the corpus callosum for the injured
group only. It can be seen that for every individual subject in the injured group, a
statistically significant increase in both NDI and ODI occurred from timepoint 1 to
timepoint 2. Following this increase, statistically significant group increases were
observed at all three timepoints post impact, but the individual response varied.
Statistical significance is taken to be p < .05, is denoted with an asterisk (*).

3.3.2

Hippocampus

Mean ROI metrics in the hippocampus (Figure 3.5) show a significant increase in the
NDI only immediately after injury that persists to four hours post injury. The first
timepoint after injury showed a 0.022 ± 0.021 (3.93%) increase in average NDI. In
contrast, no changes were observed over time in the control groups. Relevant statistical
results are described in Table 3.3.
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Figure 3.5 - Mean ROI metrics within the hippocampus for injured and control subjects.
At each point the mean of the ROI values ± SEM is shown. For NDI and ODI in the
corpus callosum a mixed effects ANOVA in SPSS showed a statistically significant group
by time interaction (p < .05). A repeated measures ANOVA was then used to determine
individual differences amongst the injured and control groups. Post-hoc pairwise
comparisons (Bonferroni corrected) were performed between individual timepoints
within each group. Statistically significant (p < .05) pairwise differences are indicated
by *. Statistical results are listed in Table 3.3 (Mixed ANOVA).
Table 3.3 lists the statistical results of the mixed effects ANOVA for both NODDI and
DTI metrics in the hippocampus. There was a statistically significant (p < .05) group by
time interaction effect for NDI only. There were no statistically significant interaction
effects (p > .05) of group by time for ODI, FA, MD, AD and RD.
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Table 3.3 - Statistical results of the mixed effects ANOVA for NODDI and DTI metrics
within the hippocampus. Statistical significance is taken to be p < .05, is denoted with a
(*) and indicates there is a statistically significant group by time interaction for that
metric within the hippocampus.
Metric
Statistical Results
NDI
F (3,39) = 7.077 p = .009
Greenhouse-Geisser
ODI
F (3,39) = 0.943 p = .382
Greenhouse-Geisser
FA
F (3,39) = 0.086 p = .967
Sphericity Assumed
MD
F (3,39) = 0.275 p = .843
Greenhouse-Geisser
AD
F (3,39) = 0.656 p = .493
Greenhouse-Geisser
RD
F (3,39) = 0.186 p = .779
Greenhouse-Geisser
The follow-up univariate analysis of NDI showed a statistically significant change over
time for the injured group while no statistically significant change over time occurred
within the control group [Injured F(3,24) = 8.648, p = .000 Greenhouse-Geisser; Control
F(3,15) = 2.015, p = .155, Sphericity Assumed]. Statistically significant changes between
individual timepoints within the injury group are depicted in Figure 3.6. Once again, we
see an increase in NDI from timepoint 1 (Baseline) to timepoint 2 in each individual
subject. Following this increase, a more heterogenous individual response occurred from
timepoints 2-4, but statistically significant group increases were observed at all three
timepoints post impact compared to baseline.

Figure 3.6 – Mean ROI values of NDI and ODI within the hippocampus for the injured
group only. It can be seen that for every individual subject in the injured group, a
statistically significant increase in both NDI and ODI occurred from timepoint 1 to
timepoint 2. Following this increase, statistically significant group increases were
observed at all three timepoints post impact, but the individual response varied.
Statistical significance is taken to be p < .05, is denoted with an asterisk (*).
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3.4 Discussion
The current study used an adult rodent model to examine the immediate effects of mild
TBI on changes in conventional diffusion MRI and NODDI metrics. While no changes in
traditional DTI metrics (FA, MD, AD and RD) were detected within the first four hours
of injury, significant differences were observed in the NODDI metrics (NDI and ODI) as
early as 1-hour post injury compared to baseline suggesting a microstructural change in
this rodent model. Specifically, both NDI and ODI were increased in the corpus
callosum immediately after impact, and NDI was increased in the hippocampus.
Therefore, this study provides evidence that NODDI metrics are sensitive to
microstructural changes within the earliest stages of this rodent model of mild traumatic
brain injury, and that these NODDI metrics are more sensitive to such changes than
traditional DTI metrics.
Neurite density index (NDI) represents the volume fraction of signal originating from the
dendrites and axons. In the current study, NDI was shown to be elevated in both the
corpus callosum and hippocampus at the first timepoint post-injury when compared to
baseline values in the mTBI group and continued to increase over time. Several
microstructural changes should be considered to explain these observations including the
many microstructural changes that have been previously shown in models of mTBI
including neuronal cell death, axonal swelling and beading, and various myelination and
remyelination processes [47,48,202]. Due to the extremely early measurement time used
in the current study (~1h post injury), the most likely of these processes that could be
occurring and contributing to the increased NDI is axonal swelling and beading. Previous
studies have indicated the presence of axonal swelling and beading in mTBI, with some
models showing this phenomenon as early as 30 minutes to 1 hour post injury [203,204],
although there is substantial heterogeneity in both the injury and animal model used in
many of these studies [56,170,171]. In the current study, the observed increase in NDI is
consistent with an increase in the interior diameter of axons due to these beading and
swelling processes. Beading and swelling may disrupt axonal transport in the very early
stages of mTBI [205,206].
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While the NODDI biophysical model is restricted to three non-exchanging
compartments, the microstructure of the brain is much more complicated. Specifically,
there are multiple constituents within the extra-cellular compartment that may contribute
to the changes in diffusion metrics observed in this study. Blood brain barrier disruption
has become a common hallmark of mTBI and would directly influence the extra-cellular
space [207]. This disruption has been shown to occur extremely quickly, as early as
minutes after injury in pre-clinical studies, and further shown to persist for years in
clinical populations [208–211]. As the blood brain barrier becomes compromised due to a
mTBI, various constituents such as blood borne proteins thrombin and fibrinogen are free
to enter the brain [38,212]. If these enter the extra-cellular space surrounding neurons,
they could contribute to diffusion changes that are indicative of a reduction in the extracellular space. Since the intra-cellular and extra-cellular space varies inversely, reduced
extra-cellular space would lead to increased intra-cellular space and consequently an
increase in the NDI metric as observed in the current study. Furthermore, this infiltration
of the extra-cellular space has been linked to microglial activation and the production of
pro-inflammatory factors [209,212].
Another component that must be considered in the interpretation of the NDI metrics is the
potential indirect contribution of glial cells. Neuroinflammatory processes have been
shown extensively in traumatic brain injury, including microglial activation and
astrocytic hypertrophy [48,61]. While glial cells are much smaller than neurons, they
outnumber them considerably [213], and the bulk effect on the scale of our voxels could
contribute to the metrics observed in this study. Neuroinflammatory processes could lead
to reduced extra-cellular space as glial cell infiltration occurs in the extra-cellular space.
Furthermore, the morphological features of glial cells vary widely under normal and
pathological conditions, leading to altered geometric properties [214,215]. On the scales
present in rodent microstructure, it is possible that the diffusion processes within and near
activated glial cells could cause a shift in the intra-cellular to extra-cellular volume
fractions and the observed change in NDI. Furthermore, in previous studies of rat and
mouse models of mTBI, compression injury, and BBB disruption, it has been shown that
microglia can respond within minutes by activating and undergoing morphological
changes [216–219]. However, the evidence to support this early glial response is
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extremely limited in mTBI models, and more commonly microglial activation is
discussed within 3-6 hours of injury and beyond [220,221]. Therefore, it is possible that
changes in glial cell morphology could produce an increase in the measured NDI but this
interpretation requires thorough histological validation to confirm such an early
neuroinflammatory response.
Orientation dispersion index (ODI), characterizes the spatial coherence or dispersion of
neurites. In the current study, ODI was also increased in the corpus callosum at the initial
timepoint post injury compared to baseline and continued to increase over time postinjury suggesting less coherence (greater dispersion) over time. In a single study in mice,
it was previously shown that an increase in glial cell load correlated with an increase in
ODI [222]. Therefore, the increase in ODI observed in the current study in the corpus
callosum could indicate an increase in glial cell density and altered morphology in the
injury group, but would be considered extremely early for a glial cell response of this
nature. Similar to the increase in glial cell population contributing to a change in ODI, the
infiltration of blood borne proteins due BBB disruption may lead to the observed increase
in ODI. It is currently unknown whether BBB disruption changes the measured NODDI
metrics in humans or pre-clinical models. A detailed histological analysis would be
required to determine whether these BBB disruptions occurred in the current model.
Interestingly, there were no statistically significant changes observed in the current study
in any of the conventional DTI metrics characterizing the corpus callosum or
hippocampus. This result is consistent with the existing literature, where there is a
paucity of work to characterize DTI changes in the first hours following mTBI. In
previous studies examining mTBI in rats and traumatic axonal injury (TAI) in mice,
statistically significant changes in diffusion metrics were detected in the corpus callosum
in the acute phase (4-6 hours) following injury. [21,176] The earliest timepoints
examined in these studies were 4-6 hours post-injury, which corresponds approximately
to the latest timepoint examined in the current study. It seems that DTI metrics may able
to detect microstructural changes in more aggressive trauma models or at later timepoints
but may lack the sensitivity to detect very early changes in mTBI models.
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3.5 Limitations
One of the common challenges with the interpretation of changes in dMRI metrics is
determining a microstructural basis for the detected change of each metric. Various dMRI
techniques have been used to study mTBI, but the results have been largely inconsistent,
leading to varied interpretations of the underlying biological processes, and providing
limited diagnostic or clinical utility [104,119,120,223–226]. While NODDI provides
biologically relevant metrics in terms of the underlying structure, it requires careful
interpretation. Particularly difficult is the fact that the intra-cellular and extra-cellular
volume fractions intrinsically vary inversely [29]. Thus, any interpretation of the increase
in NDI in the current study must also consider the possibility that a decrease in the extracellular volume fraction may be responsible. We have presented several possible
biological processes that may occur individually or in concert that could lead to
microstructural changes detectable by NODDI, however these changes were not
confirmed with histology, which was beyond the scope of this study. While neuroimaging
has many strengths, particularly the ability to provide in-vivo quantitative tissue
characterization, it is dramatically limited in resolution when compared to histological
analysis. With careful histology, the changes observed in this study could potentially be
attributed to specific biological processes occurring in the brain. This association would
in turn allow future clinical and pre-clinical studies to infer these changes on the basis of
a given NODDI metric change.
Additionally, the current NODDI biophysical model fails to take into account glial cell
contributions to the diffusion signal. It is conceivable that these contributions could be
uniquely separated based on glial cell geometry, allowing a more clearly defined picture
of the entire microstructural environment. Further, while NODDI metrics have been
shown to have minimal dependency on axon diameter [29], this has not been expressly
validated on pre-clinical models or ultra-high field systems. It should also be noted that
during our image processing steps, the registrations were visually inspected for quality
but no attempt was made to quantify image registration performance, such as a Dice
index [227].
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Finally, the current injury protocol did not include measures of injury kinematics, or
subsequent behavioural impairment and cognitive defects. Thus, there could be an
unknown bias or heterogeneity present in the imaging metrics observed that could be
explained by varied brain injury. Future studies would benefit from the characterization
of these aspects of injury. Furthermore, as anaesthesia is needed for all rodent MRI
studies we induce an unknown bias to all studies as isoflurane anaesthesia has been
shown to attenuate both positively and negatively the neuroinflammatory response
[228,229] and blood brain barrier permeability [230–232]. While we account for the
effect of anaesthesia separately with our control group, we cannot fully account for the
interaction effect of the injury response and anesthesia.

3.6 Conclusions
Increased neurite density and orientation dispersion were detected in the corpus callosum
and hippocamps of a rodent model by neurite orientation dispersion imaging in the initial
hours following a mild traumatic brain injury. These microstructural changes were
detected by NODDI in the absence of changes in traditional DTI metrics, demonstrating
NODDI to have greater sensitivity to tissue changes immediately following injury.
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3.7 Supplement

Figure 3.7 - Complete processing and analysis steps for diffusion data.
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Figure 3.8 – A) Corpus callosum (Red) and hippocampus (blue) binary ROI masks
generated and projected against the Waxholm Sprague Dawley Space Atlas template B)
Representative corpus callosum (red) and hippocampus (blue) binary ROI masks linearly
and non-linearly transformed from atlas space into diffusion space.
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Chapter 4

4

Neurite Orientation Dispersion and Density Imaging (NODDI)
in a Rodent Model of Repetitive Mild Traumatic Brain Injury.
4.1 Introduction
Mild traumatic brain injury (mTBI) has become a major health concern over the past few
decades with a substantial increase in the awareness of the detrimental health effects
associated with this injury [233]. Of particular concern is the increase in repetitive mTBI,
especially amongst young athletes. Repetitive mild traumatic brain injuries can occur in
athletes over the course of a sporting season and can lead to long-term debilitating
symptoms, neurological impairment, and death [11,234–236]. Unfortunately, much like
an initial traumatic brain injury, very little is understood about the underlying
pathophysiological features of repetitive mTBI [237–239]. Current clinical tests are
limited in their diagnostic and prognostic capabilities which leads to a vague
understanding of the dangers associated with such injuries and limits the acceptance of
legislation such as return to play guidelines for athletes [240–242]. It is important to
develop unbiased patient-specific metrics that clinicians may use to diagnose, monitor,
and grade the severity of repetitive mild traumatic brain injuries so that the long-term
consequences associated with such injuries can be assessed.
While conventional imaging techniques such as Computed Tomography (CT) or
structural magnetic resonance imaging (MRI) do not detect mTBI, advanced MRI
techniques such as diffusion magnetic resonance imaging (dMRI) have shown promise in
the detection and monitoring of mTBI [243–245]. Diffusion magnetic resonance imaging
is a magnetic resonance imaging modality that is sensitive to the displacement pattern of
water molecules in biological tissue. Many dMRI techniques provide valuable metrics by
which to determine subtle changes to the tissue microstructure, the most common of
which is diffusion tensor imaging (DTI) [246]. DTI has been used extensively in the
study of brain injury and has shown changes in various diffusion metrics such as

77

fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial
diffusivity (RD) [103,224]. While these metrics can indicate the presence and location of
a change in the underlying tissue microstructure, they often require careful interpretation
due to the inherently non-specific nature of DTI metrics. Thus, a more complete
biophysical model is necessary to capture the vast amount of information encoded within
a dMRI signal and reconstruct it in a biophysically relevant manner. To this end various
reconstruction techniques have been proposed to describe the complicated
microstructural environment in the brain and additionally capture various
pathophysiological processes, one of which is neurite orientation dispersion and density
imaging (NODDI).
NODDI applies an advanced biophysical model to partition the diffusion signal into
several unique structural elements to quantify various microstructural features such as
neurite density or orientation dispersion [29]. By measuring these microstructural
features, NODDI is able to disentangle multiple aspects of the diffusion MR signal and
monitor changes in these features independently. NODDI models three non-exchanging
tissue compartments denoted as the cerebrospinal fluid (CSF), intra-neurite, and extraneurite compartments. During signal processing, the CSF compartment is modelled as
isotropic free diffusion (Gaussian) and separated from the total signal. The CSF volume
fraction is captured by the NODDI metric IsoVF. The remaining signal is partitioned
between the intra-neurite and extra-neurite compartments. The intra-neurite fraction is
modelled as cylinders of zero-radius dispersed according to the Watson Distribution and
water diffusion within this region is highly restricted and directional. Physically this
represents the signal originating within the dendrites and axons and is quantified by the
metric neurite density index (NDI). NDI ranges as a scalar value from 0-1. The extraneurite fraction is modelled as hindered Gaussian diffusion and represents diffusion near
neurites, and within cells bodies including various types of glial cells. Note that the extraneurite volume fraction is simply 1-NDI, and thus the intra-neurite and extra-neurite
volume fractions vary inversely and provide complementary information. Finally,
NODDI provides the orientation dispersion index (ODI) metric. This index ranges from
0-1 and measures the dispersion and organization of neurites from highly coherently
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organized and directional (values near 0, e.g. white matter of the corpus callosum) to
widely dispersed (e.g. grey matter with values near 1).
Previous work using dMRI to study repetitive mTBI has shown that measurable changes
in diffusion metrics occurs and that these often do not correlate with patient symptoms, or
lack thereof [13,247,248]. Furthermore, in pre-clinical models it has been shown that
repetitive mTBI’s can produce altered diffusivity profiles within white matter tracts that
follow a pattern of amplification analogous to a dose response to multiple hits [249]. No
published studies have used dMRI to explore the immediate effects of repetitive mTBI on
diffusion measurements, but pre-clinical studies have found altered diffusion profiles
within 4 hours of mTBI in a rat model [176] and traumatic axonal injury (TAI) in a
mouse model [21]. While the injury models differed for these studies, they highlighted
the potential for dMRI to detect early changes in the microstructural environment due to
injury. To our knowledge, NODDI has never been applied to any model of repetitive
mTBI in either clinical or pre-clinical imaging. NODDI has been used in a select few
clinical studies of traumatic brain injury and concussion, but with largely varied results.
Churchill et. al. showed changes in NDI and ODI in various regions such as the corona
radiata and corpus callosum of athletes with a previous history of concussion compared
to controls [118]. Further study revealed that in athletes scanned within 7 days of a
diagnosed concussion, NDI was reduced in regions such as the corona radiata and
longitudinal fasciculus, and that this reduction persisted past the time that the athletes
were cleared to return to play [175].
Recently, we applied NODDI and DTI in the extremely early stages of a pre-clinical
model of mTBI and showed that NODDI was successfully able to detect changes in NDI
and ODI within the first two hours post injury in the corpus callosum and hippocampus
[250]. These changes were not detected with traditional DTI metrics, such as FA, MD,
AD and RD. Thus, NODDI provides a unique opportunity to explore microstructural
changes within the brain immediately following both an initial and secondary mTBI. In
the current study, we aim to extend our understanding of the early stages of brain injury
by applying NODDI to a pre-clinical model of repetitive mTBI. We hypothesize that
NODDI would be sensitive to changes in the microstructural environment of rodents

79

within the first hour of both a primary mild traumatic brain injury and a secondary mild
traumatic brain injury. Furthermore, we hypothesize that the response to the secondary
impact will be greater than that observed following the initial impact. Finally, we
hypothesize that NODDI metrics would be more sensitive to tissue microstructural
changes than traditional DTI metrics at these early timepoints.

4.2 Methods
The injury model, imaging acquisition parameters, processing, registration, and statistical
analysis methods used in the current study were identical to those listed in the previous
chapter to ensure direct comparisons could be made. These sections have been repeated
here for completeness.

4.2.1

Subjects

12 adult male Wistar rats (injury: n = 8, age at baseline scan: 112 ± 13 days, weight at
baseline scan: 278 g ± 38 g, control: n = 4, age at baseline scan: 123 ± 24 days, weight at
baseline scan: 313 ± 51 g) were acquired from Charles River. Each animal was randomly
assigned to either the control or injury group. All animal procedures were approved by
the University of Western Ontario Animal Use Subcommittee and were consistent with
guidelines established by the Canadian Council on Animal Care. Each animal was
scanned four times over 14 days according to the following timepoints: 7 days prior to
injury 1 (Timepoint 1), 1-2 hours after injury 1 (Timepoint 2), 4 days after injury 1
(Timepoint 3), and 1-2 hours after injury 2 (Timepoint 4). Timepoint 4 occurred 7 days
after timepoint 2.

Figure 4.1 - Timeline of data acquisition for animals randomly assigned to the injury
group which received both a primary and secondary closed skull controlled cortical
impact.
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4.2.2

Injury

Similar to our previous study, we chose to use the closed skull controlled cortical impact
(CCI) due to its pathophysiological response spectrum and thoroughly documented use in
rat mTBI models [189–192]. Animals were anaesthetized by induction with 4%
isoflurane followed by maintenance with 2% isoflurane. Each animal was placed in a
Kopf mouse anesthesia mask (David Kopf Instruments, LLC, USA) under a traumatic
brain injury device (TBI 0310, Precision Systems and Instrumentation, LLC, USA). For
each impact, the device was programmed to impact at an intended depth of 3.0 mm, a
velocity of 3.5 m/s and a 500-millisecond dwell time. The impact region for each animal
was shaved prior to impact. Each animal received a single closed skull controlled cortical
impact, centered at the sagittal suture, with a custom-made, 7 mm-diameter, pliant,
silicone tip. This injury model used here is in line with previous models using closed
skull controlled cortical impact to induce a mTBI [193–198]. Following controlled
cortical impact animals, anesthesia was maintained at 2% isoflurane and, using an inhouse built portable induction chamber, each animal was transferred to the small animal
MRI facility. Control animals were anaesthetized 20 minutes prior to their MRI to match
the anesthesia time between induction and scan initiation in the injured animals.

4.2.3

Acquisition

Images were acquired using a 9.4 T Bruker small animal MRI scanner at the Centre for
Functional and Metabolic Mapping located within the Robarts Research Institute at the
University of Western Ontario. Imaging included the acquisition of high-resolution
anatomical images and NODDI in all animals. Anatomical images were acquired for
each subject at the beginning of each session using a T2-weighted TurboRARE pulse
sequence (8 averages, 32 slices, slice thickness = 500 µm, FOV 32 x 32 mm, matrix size
160 x 160, in-plane resolution = 200 x 200 µm, TE = 44.00 ms, TR = 7.0 s, Echo Spacing
= 11.00 ms, Rare Factor 8, total acquisition time = 14 min)[199]. The NODDI diffusion
sequence was incorporated into a multi-shot, spin echo, echo-planar-imaging (EPI)
acquisition pulse sequence (4 shots, 32 slices, slice thickness = 500 µm, FOV 40 x 40
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mm, matrix size 160 x 160, in-plane resolution = 250 × 250 µm, TE = 26.71 ms, TR =
2.5 s).
The NODDI diffusion scheme used was previously described in detail and was shown to
produce reproducible and reliable results at 9.4 Tesla [200]. Briefly, a q-space sampling
scheme was used across two-shells, optimized according to Caruyer et. al. [146], with a
total of 90 directions. In shell one, 30 directions with b-value = 1000 s/mm2 were
obtained using the following diffusion gradient parameters: gradient strength
(G) = 172.85 mT/m, time between the start of the first and second diffusion pulse
(Δ) = 14 ms, the duration of a single gradient pulse (δ) = 4.5 ms. In shell two, 60
directions with b-value = 2000 s/mm2 were obtained using the following diffusion
gradient parameters: gradient strength (G) = 345.70 mT/m, time between the start of the
first and second diffusion pulse (Δ) = 14 ms, the duration of a single gradient pulse
(δ) = 4.5 ms. Ten b = 0 s/mm2 were interspersed evenly throughout the acquisition. Four
averages were used to ensure adequate signal to noise ratio (SNR) in the higher b-value
shell. The imaging time for each acquisition (four averages) was 66 minutes 36 seconds.
A single reverse phase encoded b=0 volume was also acquired prior to the diffusion
sequence for subsequent use in image processing to correct image distortions.

4.2.4

Processing

Brain masks were produced using the 3D Pulse Coupled Neural Network (PCNN) tool
for MATLAB (R2019a) [150]. Raw data were pre-processed using fMRI Software
Library (FSL, v. 6.0.1, Oxford, UK). TOPUP [148] followed by EDDY [149] was used to
correct for eddy current induced distortions as well as susceptibility-induced distortions.
The FDT toolbox (v. 5.0) was used to produce maps of FA, MD, AD, and RD. The
NODDI Matlab toolbox (available from the University College London (UCL)
Microstructure Imaging Group) was then used to produce maps of NDI, ODI, and IsoVF.
All diffusion maps were produced within each subject’s native diffusion image space.
While IsoVF is produced during the processing steps, our previous work has indicated it
to have extremely high variability and low reproducibility with this scan protocol and
therefore we limit our analysis to NDI and ODI only.
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4.2.5

Registration

For each subject, the first volume in each diffusion data set (b = 0) was aligned with its
corresponding anatomical images using a linear registration in FSL (FLIRT) [151]. The
anatomical image for each subject was then aligned to the Waxholm Space Atlas Sprague
Dawley template [152] using a linear transformation (FLIRT) followed by a non-linear
transformation (FNIRT) [153] in FSL. Binary ROI masks of the corpus collosum and
hippocampus from the Waxholm Space Atlas, were then transformed into the anatomical
space of each individual subject by inverting the preceding non-linear transformations.
Finally, the masks were brought into diffusion space using the inverse transformation
matrix from the b0 image to anatomical image registration. Thus, each mask was brought
into each subject’s individual native diffusion image space. Each mask was then eroded
by a single voxel around the edges to avoid partial volume effects. Masks were visually
inspected to ensure accuracy. Please refer to 3.7 for processing steps and representative
visualizations of ROI binary masks.

4.2.6

Statistical Analysis

For each subject, at each timepoint the mean value of each individual scalar metric within
each relevant ROI was extracted using fslstats and the relevant binary mask. A mixed
ANOVA in SPSS [201] was used for each metric to determine if there were statistically
significant interaction effects (p < .05) between controls and injured animals over time.
This test examined whether each metric changed over time and whether those changes
were different between the two groups. Mauchly’s Test was used to determine if the
assumptions of sphericity were violated. In cases where the assumption of sphericity was
rejected, the Greenhouse-Geisser correction was used. In each case where a statistically
significant interaction effect occurred, a follow-up repeated measures ANOVA was run
separately on each group (injured and controlled) to determine if there were statistically
significant changes (p < .05) in the diffusion metric over time within each group. Further,
post-hoc analysis was used to determine which timepoints differed within each group
(Bonferroni corrected). Finally, in an effort to determine if the response to each hit
differed in those metrics which showed a statistically significant change from baseline, a
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paired t-test on the response to injury 1 and injury 2 was used. The response to injury 1
was defined as the difference between timepoint 1 and 2, while the response the injury 2
was defined as the difference between timepoint 3 and 4.

4.3 Results
Data were successfully acquired from all 12 subjects. Figure 4.2depicts single subject raw
data, NODDI scalar maps, and DTI scalar maps. The following timepoints were used in
this study: Timepoint 1 (or baseline scan) obtained 7 days prior to injury, Timepoint 2
began at 62 ± 14 minutes post-injury 1, Timepoint 3 began at 98 ± 3 hours post-injury,
and Timepoint 4 began at 66 ± 11 minutes post-injury 2.

Figure 4.2 - Single-subject axial slices of A) raw diffusion data B) Neurite Density Index
(NDI), C) Orientation Dispersion Index (ODI), D) Isotropic Volume Fraction (IsoVF), E)
Fractional Anisotropy (FA), F) Mean Diffusivity (MD), G) Axial Diffusivity H), Radial
Diffusivity. The diffusion images were acquired with a multi-shell sequence (10 b= 0
s/mm2, 30 b = 1000 s/mm2 and 60 b= 2000 s/mm2) incorporated into a multi-shot, spin
echo, echo-planar-imaging (EPI) acquisition pulse sequence (4 shots, 32 slices, slice
thickness = 500 µm, FOV 40 x 40 mm, matrix size 160 x 160, in-plane resolution = 250
× 250 µm, TE = 26.71 ms, TR = 2.5 s).
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Figure 4.3 – Mean ROI metrics within the corpus callosum for injured and control
subjects. Each data point depicts the mean value of an individual subject ± SEM. Note,
injury 1 took place at timepoint 1 and injury 2 took place at timepoint 4. For NDI and
ODI in the corpus callosum a mixed effects ANOVA in SPSS showed a statistically
significant group by time interaction (p < .05). A repeated measures ANOVA was then
used to determine individual differences amongst the injured and control groups. Posthoc pairwise comparisons (Bonferroni corrected) were then determined between
individual timepoints within each group. Statistically significant (p < .05) pairwise
differences are indicated by *.
In the Corpus Callosum, there was a statistically significant (p < .05) group by time
interaction effect for NDI [F(3,30) = 4.161, p = .033, Greenhouse-Geisser corrected] and
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ODI [F(3,30) = 3.851, p = .047, Greenhouse-Geisser corrected]. There was no
statistically significant interaction effect (p > .05) of group by time for FA, MD, AD and
RD.
From the subsequent univariate repeated measures ANOVA, it can be seen that for both
NDI and ODI there was a statistically significant change over time for the injured group,
while no statistically significant change over time occurred within the control group for
these metrics.
Table 4.1 - Mean ROI diffusion metrics that were shown to be significantly different
between injured and control subjects. Values shown are mean ± SD.
Metric
Timepoint
Injured
Control
NDI

ODI

1

0.524 ± 0.008

0.530 ± 0.010

2

0.540 ± 0.009

0.539 ± 0.014

3

0.539 ± 0.020

0.537 ± 0.011

4

0.558 ± 0.017

0.536 ± 0.013

1

0.303 ± 0.014

0.323 ± 0.017

2

0.340 ± 0.012

0.327 ± 0.015

3

0.322 ± 0.023

0.326 ± 0.016

4

0.322 ± 0.027

0.325 ± 0.019

Table 4.2 - Statistical Results of a repeated measures ANOVA for NDI and ODI within
the corpus callosum. All statistical analysis was run in SPSS (v. 26).
Metric Statistical Results
NDI
ODI

Injured

F (3,21) = 13.618

p = .001

Greenhouse-Geisser

Control

F (3,9) = 1.318

p = .328

Sphericity Assumed

Injured

F (3,21) = 9.504

p = .000

Sphericity Assumed

Control

F (3,9) = 3.431

p = .066

Sphericity Assumed
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Figure 4.4 - Mean ROI values in the injured group of NDI and ODI within the corpus
callosum. Note, injury 1 took place at timepoint 1 and injury 2 took place at timepoint 4.
For every individual subject in the injured group, an increase in both NDI and ODI
occurred from baseline to the first mTBI. Following this individual response varied
across the subsequent timepoints.
Similar to our previous study, it can be seen that for every individual subject both ODI
and NDI increased after the initial mTBI. Using and two-tailed paired t-test it was shown
that for NDI there was no statistically significant difference in the response to injury 1
and injury 2 in the corpus callosum (p = .68). For ODI there was a statistically significant
difference in the response to injury 1 and injury 2 (p =.00)

87

Table 4.3 – NDI and ODI values for each subject in the corpus collosum of the injured
group. There was no statistically significant difference between D1 and D2 for NDI
indicating a similar response to injury 1 and injury 2. For ODI a statistically significant
difference between D1 and D2 existed (p =.00).
Metric

Subject

NDI

Timepoint

Timepoint

1

2

1

0.517

0.536

2

0.531

3

Mean

Injury 2
D1

D2

Timepoint

Timepoint

3

4

0.019

0.543

0.543

0.000

0.551

0.020

0.539

0.562

0.023

0.521

0.545

0.024

0.536

0.556

0.019

4

0.526

0.547

0.021

0.544

0.542

-0.002

5

0.512

0.525

0.013

0.506

0.540

0.0346

6

0.522

0.538

0.016

0.518

0.555

0.0373

7

0.525

0.530

0.005

0.567

0.588

0.0208

8

0.537

0.547

0.010

0.557

0.574

0.0163

0.524 ±

0.540 ±

0.016 ±

0.539 ±

0.558 ±

0.019 ±

0.008

0.009

0.006

0.020

0.017

0.014

1

0.282

0.320

0.037

0.300

0.335

0.035

2

0.307

0.343

0.035

0.329

0.327

-0.001

3

0.301

0.336

0.034

0.310

0.299

-0.010

4

0.310

0.353

0.042

0.334

0.301

-0.034

5

0.310

0.339

0.029

0.299

0.311

0.012

6

0.294

0.328

0.035

0.301

0.293

-0.008

7

0.327

0.355

0.028

0.364

0.376

0.012

8

0.292

0.349

0.057

0.340

0.338

-0.002

0.303 ±

0.340 ±

0.037 ±

0.322 ±

0.322 ±

0.004 ±

0.014

0.012

0.009

0.023

0.027

0.020

Mean
ODI

Injury 1
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Figure 4.5 - Mean ROI metrics within the hippocampus for injured and control subjects.
Each data point depicts the mean value of an individual subject ± SEM. Note, injury 1
took place at timepoint 1 and injury 2 took place at timepoint 4. No statistically
significant group by time interactions (p > .05) were detected.
In the hippocampus, there was no statistically significant interaction effect (p > .05) of
group by time for NDI, ODI, FA, MD, AD and RD. As no group by time interaction
effect occurred in the hippocampus no subsequent statistical analysis was performed.
Please refer to Figure 4.5 for ROI values.
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4.4 Discussion
This study examined the immediate changes in NODDI and DTI metrics in a rodent
model of repetitive mild traumatic brain injury. The NODDI metrics NDI and ODI
showed statistically significant increases in the corpus callosum within the first two hours
after the initial mTBI, while only NDI showed a further increase immediately following
the second mTBI one week later. There were no changes in any diffusion metrics in the
hippocampus. The increase in NDI in the corpus callosum suggests a change in the
microstructural environment immediately following each mTBI. However, converse to
our hypothesis, there were no changes in diffusion metrics that were greater following the
second injury compared to the first injury on a group level. Interestingly, individual
response to the second mTBI varied substantially.
Neurite density index (NDI) was shown to increase immediately following the initial
mTBI and the second mTBI in the corpus callosum. Following the initial injury, an
average increase in NDI of 0.016 ± 0.006 (3.22%) was found and following the second
injury and average increase of 0.0187 ± 0.014 (3.41%). This result agrees with our
previous study which also showed an increase of 0.046 ± 0.026 (7.83%) in NDI
compared to baseline in the corpus collosum [250]. Further, it was shown that the
response to injury 1 did not significantly differ from the response to injury 2 in the corpus
collosum. When referring to the mean values of NDI over time we see (in order): 0.524,
0.540, 0.539, 0.558 (refer to
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Table 4.3). From this we may infer that the pathophysiological response that NDI has
measured did not resolve between injury 1 and injury 2 (noting there was no significant
difference between timepoint 2 and 3), and that the second injury in fact compounded on
the first with equal magnitude. This finding could provide a clue as to the dose-like effect
of multiple mTBI’s often seen in the clinical setting.
Common interpretations of increased NDI suggest an increase in the volume or number
of dendrites and axons within the corpus callosum. The most likely explanation would be
an increase in the inner diameter of axons due to axonal swelling and beading. Axonal
swelling and beading have been shown by ex-vivo histology as a common
microstructural change in mTBI [167,251,252]. In addition, these pathological processes
have been shown to occur within as little as thirty minutes following injury in mTBI
models [56,171]. Therefore, the increase in NDI following both the first and second
mTBI in the current study could be due to these processes. Furthermore, in the current
study it was shown that four days after the initial impact, NDI was not statistically
different than baseline, suggesting that the effect of the initial mTBI on NDI had, at least
in part, resolved in the intervening time.
While the NODDI biophysical model technically encompasses strictly the tissue
components of the microstructure, there are significantly more components contained
within the diffusion signal. Specifically, the various constituents in the extra-neurite
compartment must be considered as this is inversely related to NDI (e.g. an increase in
NDI could be due to a decrease in the extra-neurite space). Blood brain barrier disruption
been extensively shown in mTBI and this disruption has been shown to occur as early as
minutes after injury in pre-clinical studies [208–211]. This disruption compromises the
ability of the BBB to restrict passage of various factors such as blood borne proteins from
entering the extra-neurite space [38,212]. As these enter the extra-neurite space
surrounding neurons, they could contribute to diffusion changes that are measured as a
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reduction in the extra-neurite space, thus contributing to the increases observed in the
NDI measurement.
Neuroinflammatory processes have been heavily implicated in the initial and long-term
response to mTBI [72,253,254]. It has been shown that the response is complex, at times
acting in a neuroprotective manner, and others in a neurodegenerative manner [255–257].
Furthermore, as shown in Figure 3, it appears that the NDI response and its outcome
vary dramatically on an individual basis, consistent with the heterogeneous individual
response to mTBI seen in patients [258,259]. In the current study it is possible that
increased glial cells within the extra-neurite compartment contributed to a decrease in the
volume of the extra-neurite compartment. As the extra-neurite and intra-neurite NDI
components must sum to unity, this would lead to the measured increase in NDI apparent
here. Additionally, the glial cell response has been shown to occur minutes after injury in
various brain injury models such as TBI and BBB disruption [216–219]. Once again,
these processes could lead to a reduction in the extra-neurite compartment and the
measured NDI increase. Of particular interest in the discussion is the heterogeneous
response of NDI in individuals following the first mTBI. While each individual subject
showed an increase in NDI following the initial hit, the changes observed on day four
varied widely amongst individuals. As discussed in our previous paper, while the
relationship between NDI and neuroinflammation is an interesting possibility, a
detectable glial response is more commonly thought to begin within 3-6 hours post mTBI
[220,221] and further confirmation through histology would be needed to support this
interpretation.
Orientation dispersion index (ODI) also increased in the corpus callosum from baseline to
our initial timepoint post injury consistent with our previous study. Following the initial
injury, an average increase in ODI of 0.037 ± 0.009 (10.88%). This increase was no
longer present four days after impact. Interestingly, there was no further increase in ODI
following the second mTBI. As described previously, the increase in ODI following the
first injury indicates an increase in the dispersion of white matter tracts within the corpus
callosum, leaving them less ordered along their predominant fiber direction. Axonal
disorganization has been heavily implicated in mTBI, showing altered anisotropy
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amongst fiber bundles and decreased alignment [260–262]. There are several other
potential explanations for this change including the infiltration of blood constituents to
the extra-neurite space, although there is currently no literature exploring the relationship
between ODI and BBB disruption. Additionally, it has been shown that an increase in
glial cell load correlates to an increase in ODI and thus it is possible that a
neuroinflammatory response may account for the measured changes [222]. However, as
discussed previously it is unlikely the glial response accounts for the measured signal
change at the very early time point examined in the current study. Here again it is
extremely important to acknowledge the heterogenous ODI response following the initial
timepoint. Following the initial mTBI, the measured changes in ODI on an individual
basis (Figure 3) vary substantially potentially indicating a varied individual response to
trauma.
No statistically significant changes were observed in NDI or ODI in the hippocampus.
This result was surprising as our previous study detected an increase in NDI but not ODI
immediately following a single mTBI. It should be noted though that while the previous
increase in NDI in the hippocampus was statistically significant, the magnitude was only
0.022 ± 0.021 (3.93%) at the earliest timepoint. Further, the earliest timepoint in our
previous study began at 75 ± 16 minutes, while in the current study the earliest timepoint
began at 62 ± 14 minutes. While this is not a large time difference in relation to the
overall scan time of 66 minutes, it is possible that at these extremely early timepoints and
the very small magnitude of change, the NDI changes observed in the first study did not
have time to develop in the current study. Future studies would benefit by looking into
this change with larger sample sizes and precisely matched timepoints.
It is also noteworthy that no statistically significant changes were observed in any DTI
metrics in the corpus callosum or hippocampus following either the first or repeated
mTBI. This agrees with our previous findings indicating that using the current scan
protocol DTI lacks the sensitivity to detect diffusion changes immediately following
mTBI [250].
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4.5 Limitations
While dMRI techniques are highly sensitive to subtle changes in diffusion parameters,
the results must be carefully interpreted to make inferences with regard to the underlying
microstructural changes [263,264]. NODDI uses a biophysical model to partition the
diffusion signal into physically relevant compartments, but still requires interpretation as
it does not account for various constituents of the extra-neurite compartment such as glial
cell contribution to the diffusion signal. In the current study we have provided possible
biological explanations that could contribute to the measured signal changes, but these
would require careful histological validation. It may also be possible in the future to
partition the NODDI model further, thus separating out the unique diffusion
characteristics of glial cells such as microglia and astrocytes. This would prove
immensely valuable in the study of brain injury and neurodegeneration, of which
neuroinflammation has been heavily implicated. Furthermore, it should be noted that
while NODDI has been heavily validated for human studies at clinical field strengths,
some characteristics such as axon diameter dependency in rodents at ultra-high fields
have not been expressly explored. While we have shown these metrics to be reproducible
in a rodent model at 9.4 Tesla, it would be useful to further validate the metrics
specifically at this field strength [200].
The current injury protocol did not take into account careful examination of the kinematic
properties of the injury, such as sheer forces and acceleration. Additionally, no
behavioural measures were taken to determine cognitive defects associated with this
injury. When observing the heterogenous individual response to the second injury in this
model, it would be extremely valuable to have this additional information, such that any
covariance in the injury model may be accounted for. While the impact was consistent
amongst subjects, adding this covariance could account for individual differences in the
result of that impact. Finally, it would be beneficial to track these subjects for several
weeks following repetitive mTBI’s to determine long-term outcomes and relate to the
individual responses seen in the current study. This in turn could shed light on the
immense variance seen in terms of recovery in the clinical patient population.
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4.6 Conclusions
NODDI was successfully able to detect changes in NDI and ODI in the brain of rodent’s
immediately following a first and a second closed skull controlled cortical impact. The
measured changes largely did not differ between the first and second impact when
comparing groups but varied dramatically on an individual basis. This leads us to
conclude the immediate response to repetitive mTBI is extremely heterogeneous and
could provide clues with regard to the varied recovery rates evident in the clinical patient
population.
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Chapter 5

5

Summary and Conclusions
5.1 Overview and Research Questions
Mild traumatic brain injury (mTBI) is known to contribute to a diverse range of shortand long-term detrimental health effects, ranging from nausea and dizziness to extreme
memory loss, mental health issues, and death [44,265,266]. Currently, there is no
pathognomonic test that allows clinicians to diagnose, assess the severity, or monitor the
recovery of patients suffering from a mTBI. Most medical imaging techniques are unable
to detect mTBI as large scale changes such as expanding epidural hematoma are not
present [5,6]. Further, it is nearly impossible to study the immediate changes in a clinical
setting because patients simply are not available to study during this time period. Thus,
the complete pathological response occurring in the early stages of mTBI is still largely
unknown, limiting diagnosis, prognosis, and development of treatment.
One medical imaging modality that has shown promise in the detection of microstructural
changes in mTBI is neurite orientation dispersion and density imaging (NODDI). NODDI
is a biophysical modelling technique that separates a dMRI signal into three unique
compartments termed the intra-neurite, extra-neurite, and CSF compartments [30]. This
model allows detection of microstructural changes, such as axonal beading, separate from
changes within the extra-neurite compartment, such as neuroinflammatory effects,
providing a unique imaging perspective on the various pathological processes taking
place in the immediate stages following mTBI.
The overreaching objective of this thesis was to apply NODDI in the early stages of a
rodent model of mTBI at 9.4 Tesla in an effort to understand and quantify the
pathophysiological response to mTBI. Specifically, this thesis addressed three main
research questions: 1) What is the scan-rescan reproducibility of NODDI in a rat model at
9.4 Tesla, and what biological effects is NODDI capable of detecting with feasible preclinical sample sizes? (Chapter 2); 2) Is NODDI capable of detecting changes within
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early stages of a rat model of mTBI, and if so, what underlying physiological processes
do they represent? (Chapter 3); and 3) Is NODDI capable of detecting changes
immediately following both a first and second injury in a rodent model of mTBI, and is
this response to injury different (Chapter 4)?

5.2 Chapter Summaries and Significance
5.2.1

Chapter 2

In Chapter 2, the reproducibility of NODDI in a rodent model at 9.4 Tesla was evaluated.
Eight adult male Sprague Dawley rats were subjected to a scan-rescan protocol on a 9.4
Tesla Agilent MRI. The coefficient of variation (CV) was used to assess the
reproducibility and reliability of NODDI and provide insight into necessary sample sizes
and the minimum detectable effect size. NDI and ODI showed high reproducibility both
between and within subjects under both a voxel-wise and ROI analysis. Furthermore, it
was found that small biological changes (< 5%) may be detected with feasible sample
sizes (n < 6-10). In contrast, IsoVF was found to have low reliability and reproducibility,
requiring very large sample sizes (n > 50) for biological changes to be detected. This
work represents the first publication quantifying the reproducibility of NODDI metrics at
9.4 Tesla in a rat brain and provides valuable insights as to the number of subjects
necessary to detect a given biological effect.

5.2.2

Chapter 3

With NODDI shown to be reproducible and capable of detecting subtle changes with
feasible sample sizes, NODDI was applied to a rodent model of mTBI to determine
whether microstructural changes could be detected immediately following injury.
Secondary to this we sought to compare the sensitivity of NODDI metrics to standard
DTI metrics in this model. Nine adult male Wistar rats underwent a single closed skull
controlled cortical impact followed immediately by NODDI repeated three times from 14 hours post injury. Six sham control rats were scanned under the same conditions
without injury. ROI analysis showed a statistically significant increase in NDI in both the
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hippocampus and corpus callosum following injury, while ODI showed an increase in
only the corpus callosum. These changes occurred at the first timepoint post-injury (≈ 1
hour) and stayed elevated through the final timepoint (≈ 4 hours). No statistically
significant changes were observed in the sham control animals for NDI, nor ODI. No
statistically significant changes were found in FA, MD, AD, or RD metrics in either
group. These metrics indicate an immediate change to the microstructural architecture in
the brain following mTBI and provide insight into the pathophysiological response to
injury. Further, these results indicate that NODDI metrics are more sensitive than DTI
metrics to early microstructural changes in the current injury model. This study
represented the first application of NODDI to a pre-clinical rodent model of mTBI at 9.4
Tesla, and the first study to investigate alterations in diffusion metrics within the first 4
hours post-mTBI.

5.2.3

Chapter 4

In Chapter 4, we extended this model of mTBI to determine the response to repetitive
mTBI in a rodent model using NODDI. Eight adult male Wistar rats underwent two
closed skull controlled cortical impacts followed immediately by a NODDI acquisition 12 hours post injury. The impacts were separated by one week. Animals were scanned at
four separate timepoints: 1 week before injury, immediately following the first mTBI,
four days following the first mTBI, and immediately following the second mTBI. In
injured animals, both NDI and ODI showed a statistically significant increase
immediately following the first mTBI in the corpus callosum. NDI showed a similar
increase following the second mTBI in the corpus callosum while ODI did not. No
statistically significant changes were observed in the hippocampus of injured animals nor
any region in the sham control animals. Furthermore, no statistically significant changes
were found in FA, MD, AD, or RD metrics in either group. The observed changes
support our previous findings showing an immediate change to the microstructure of the
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brain following an initial mTBI and suggest further disruption of the tissue microstructure
following the second mTBI. Of particular note in this study was the heterogeneous
individual response to injury following the second mTBI. This finding could provide
insight into the widely varied outcomes and recovery amongst the clinical population
exposed to multiple mTBI. This study represented the first application of NODDI to a
pre-clinical rodent model of repetitive mTBI at 9.4 Tesla, and the first study to
investigate alterations in diffusion metrics immediately following mTBI in any
application.

5.3 Limitations
In this section, I discuss the major limitations of the chapters individually followed by a
discussion of general limitations of the thesis.

5.3.1

Chapter 2

There are several limitations to acknowledge within this study, the first of which is the
fact that the quality of the linear and non-linear registrations was not specifically
quantified. While they were visually assessed for quality, future studies may benefit from
quantification of the registration process with Dice index analysis [227]. Secondly,
optimized parameters such as angular resolution, image resolution, and b-value
combination for rodent NODDI at 9.4 Tesla has not been fully explored. While these
considerations must be balanced against practicalities such as scan time for any in-vivo
study, it would be beneficial to do a thorough quantification and comparison of these
parameters. In humans, the optimal b-values were explored through simulation and invivo study, and it was found that as long as two shells with moderate b-value were used,
the precise choice of b-value made minimal difference and was minimally affected by
axon diameter [29]. Future studies would benefit from a similar analysis within a rodent
brain at 9.4 Tesla.
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5.3.2

Chapter 3 and 4

These chapters follow the same experimental protocol and thus have the same limitations.
Similar to Chapter 2, these studies suffer from lack of image registration quantification
and NODDI parameter optimization. Additionally, they are limited by the absence of
histological validation. As the NODDI reconstruction is limited to a 3-compartment
model, it fails to uniquely account for contributions from pathophysiological processes
such as blood-brain barrier disruption or glial cell response. It could be that these
processes contributed to the changes observed in this study, but without histological
validation, any interpretation is uncertain. Future studies would benefit from a careful
histological analysis. Additionally, no behavioral measures were acquired to determine if
the injury model used did in fact produce a mTBI. The varied response on an individual
level could possibly be explained in part by behavioural analysis of the subjects. Finally,
while the controlled cortical impact was landmarked and standardized for each injury, no
metrics were obtained quantifying kinematic properties such as rotation and translation of
the head. These metrics could be integral in further explaining sources of variation in the
resulting NODDI metrics.

5.3.3

General Limitations

Over the course of this thesis, significant upgrades took place within the lab, one of
which was the upgrade from an Agilent 9.4 Tesla scanner to a Bruker 9.4 Tesla scanner.
Thus, the work in Chapter 2 was performed on the former system while the work in
Chapter 3 and 4 was performed on the latter system. This included entirely new
hardware, software, pulse sequences, data storage, and raw data reconstruction. Basic
SNR calculations were performed on a small number of data sets showing improved SNR
with the Bruker system (≈ 20%), but a thorough quantification of NODDI performance
between the two systems was not performed. It should also be noted that in Chapter 2,
Sprague Dawley rats were used, while in Chapter 3 and 4, Wistar rats were used due to
protocol limitations. While we do not anticipate a large change in results between the two
strains, it is important to note the difference.
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5.4 Future Directions
5.4.1

NODDI Optimization at 9.4 Tesla

In Chapter 2 of this thesis, NODDI was shown to be reproducible and sensitive to small
changes in NDI and ODI metrics. Although this allowed these parameters to be used for
future studies, it is currently unknown if they are in fact the optimal parameters. As such
the optimization of the NODDI acquisition at 9.4 Tesla would provide a valuable
framework for future studies. Specifically, this study would focus on the optimization of
angular resolution, b-value magnitude, and b-value distribution amongst and between
shells. Furthermore, this would provide optimized protocols under set scan times, which
could be achieved on common 9.4 Tesla preclinical scanners. The same approach used to
optimize NODDI acquisition in humans could be applied to optimize the acquisition in
rodents [29,267]. This work would provide a road map for researchers to apply NODDI
to extensive preclinical applications.

5.4.2

Histological Validation of NODDI Metric Changes Observed
Following mTBI

As stated in both Chapter 3 and 4, the major limitation in these studies involves
interpretation of the observed changes in NODDI metrics. To overcome this, careful
histological validation would be necessary to confirm these findings. We propose
repeating these studies with a larger cohort and a greater histological focus. Specifically,
we propose amyloid precursor protein (APP) immunohistochemistry and silver staining
to characterize axonal pathology [195], ionized calcium-binding adaptor protein-1 (IBA1) immunohistochemistry to characterize microglial activation [268], Glial fibrillary
acidic protein (GFAP) to detect astrogliosis [269,270], and the evaluation of BBB
disruption through the use of Immunoglobulin G (IgG) staining [271] and Evans Blue
extravasation assay [272]. By performing each of these stains, we would be able to
disentangle the information contained in the NODDI metrics, leading to a more thorough
understanding of how the pathophysiological response contributes to these changes.

101

5.4.3

Combined PET/MRI to Visualize Microglial Activation in mTBI

Microglial activation has been shown as an important neuroinflammatory response to
brain injuries such as mTBI [73,273]. Activation can occur within hours and persist many
years, often occurring at sites of neuronal degeneration and axonal alterations [274–276].
As such, non-invasive in-vivo imaging of microglial activation presents a unique
possibility to measure a component of the neuroinflammatory response to injury. The
PET ligand [18F]-DPA-714 binds with high specificity to TSPO, an 18-kDa translocator
protein [277]. Activation of microglia leads to increased mitochondrial TSPO expression,
while expression of TSPO under normal physiological conditions is relatively low and
restricted to specific regions [278,279]. Due to the specific binding affinity, ability to
cross the blood-brain barrier, and negligible levels of endogenous [18F]-DPA-714, it is a
prime candidate to visualize the activation of microglia in-vivo in mTBI [280]. The use of
combined PET/MRI allows for high-resolution anatomical imaging using MRI, while
obtaining the dynamic pathophysiological information from PET. Immediately following
imaging, animals would be sacrificed and immunohistochemistry staining (Iba-1) would
be used to verify and localize activation of microglia.
The ability to dynamically image microglial activation will allow for repeated-measures,
longitudinal studies of various normal and pathological processes, which has previously
been impossible within histological studies. This in turn could lead to a more thorough
and accurate understanding of the development and response of the central nervous
system.

5.4.4

In-vivo Imaging of Glial Cells using Diffusion Weighted MRI

Glial cells are the most abundant non-neuronal cell type within the central nervous
system (CNS) [33]. These cells provide extensive support throughout the brain and spinal
cord through the maintenance of homeostasis and various supporting activities for the
neuron [35]. As discussed in this thesis, glial cells are heavily implicated in the response
to mTBI. Although extensive histological techniques have been developed to visualize
glial cell load and morphology ex-vivo, in-vivo techniques are sparse. Here, we propose
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the use of diffusion weighted MRI to dynamically visualize and quantify glial cells invivo in rodents.
Diffusion weighted MRI would be acquired on an ultra-high field (9.4 Tesla) small
animal scanner. To reconstruct the signal, we would follow the method employed in the
NODDI toolbox (available from the UCL Microstructure Imaging Group) with a
modification to extract the unique contribution from the glial cell compartment. Thus, the
total diffusion signal would be separated into four non-exchanging microstructural
compartments: the intra-neurite fraction (volume fraction of water within the axons and
dendrites), the extra-neurite volume fraction (volume fraction of water near neurons), the
CSF volume fraction (volume fraction of isotopically free diffusing water), and the glial
volume fraction (volume fraction of water within the glial cells). While some studies
have shown the contribution of glial cells to these compartments [222], we currently are
not aware of any techniques which expressly define the glial cell contribution uniquely.
Due to the size (approximately one tenth the size of a neuron), we expect diffusion to be
minimal and non-directional within glial cells, leading to high diffusion signal in regions
of high glial cell load. This diffusion pattern is unique within the microstructural
environment when compared to neurons and dendrites (highly restricted and directional),
the extracellular space (hindered and directional), and the CSF (free, non-directional).
Initially, simulations could be employed based on those described in [267,281] to
determine optimal diffusion acquisition parameters based on known glial cell structure.
These parameters would then be applied to in-vivo rodent models of mTBI. Immediately
following acquisition, animals would be euthanized and perfused in preparation for
histology. Established histological stains such as Iba-1 and GFAP would be used to detect
the presence of glial cells. Reconstructed diffusion images would then be registered and
validated against histological images. The use of diffusion weighted MRI here will
address the significant gap that exists between ex-vivo and in-vivo capabilities of imaging
glial cells.

103

5.5 Significance and Impact
mTBI is a diverse and challenging injury to diagnose. Clinical presentations vary
dramatically, as do patient outcomes [4,265,282]. To this point, the scientific literature
with regard to mTBI is largely divergent, except to show the potential for debilitating and
damaging health effects [2,283]. While these health effects are well known now, the
underlying pathophysiological processes that produce these effects are largely unknown.
Without a clear understanding of these processes it is impossible for clinicians to
accurately diagnose and assess mTBI in patients. Neurite orientation dispersion and
density imaging provides an opportunity to study these microstructural changes in-vivo.
This thesis advances the capabilities of NODDI in a pre-clinical model of mTBI. When
this work began, only a single publication had applied NODDI in a preclinical setting
[144], but the reliability and reproducibility of the technique in this setting was unknown.
We have provided, for the first time, quantification of the reproducibility of this
technique at 9.4 Tesla and provided details with regard to the measurable biological
effect’s detectable with this technique. This information will enable researchers to
similarly apply this technique to countless pre-clinical models of neuronal health, disease,
and injury.
Simultaneously, this thesis advances our understandings of the early microstructural
changes present in mTBI. Clinically it is impossible to study these changes for the first
several hours following a brain injury as patients rarely present early following injury and
if they do, they cannot be kept in a scanner for any appreciable length of time. This thesis
presents the first application of NODDI in a pre-clinical rodent model of both initial and
repetitive mTBI at 9.4 Tesla. We have provided, for the first time, in-vivo evidence of
changes in NODDI metrics detectable within the first hour following both an initial and
secondary mTBI in a rodent model. These changes indicate detectable underlying
microstructural changes that occur rapidly after a mTBI. This knowledge indicates the
potential of NODDI to be further developed into a diagnostic imaging technique capable
of quantifiably detecting mTBI in-vivo.
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Appendix B: Health Sciences Research Ethics Board Approval Notices

AUP Number: 2018-176
PI Name: Brown, Arthur
AUP Title: Investigations of CNS Injury and Regenerative Therapies
Approval Date: 03/01/2019
Official Notice of Animal Care Committee (ACC) Approval:
Your new Animal Use Protocol (AUP) 2018-176:1: entitled " Investigations of CNS Injury and Regenerative
Therapies "
has been APPROVED by the Animal Care Committee of the University Council on Animal Care. This approval,
although valid for up to four years, is subject to annual Protocol Renewal.
Prior to commencing animal work, please review your AUP with your research team to ensure full understanding
by everyone listed within this AUP.
As per your declaration within this approved AUP, you are obligated to ensure that:
1) Animals used in this research project will be cared for in alignment with:
a) Western's Senate MAPPs 7.12, 7.10, and 7.15
http://www.uwo.ca/univsec/policies_procedures/research.html
b) University Council on Animal Care Policies and related Animal Care Committee
procedures
http://uwo.ca/research/services/animalethics/animal_care_and_use_policies.htm
2) As per UCAC's Animal Use Protocols Policy,
a) this AUP accurately represents intended animal use;
b) external approvals associated with this AUP, including permits and
scientific/departmental peer approvals, are complete and accurate;
c) any divergence from this AUP will not be undertaken until the related Protocol
Modification is approved by the ACC; and
d) AUP form submissions - Annual Protocol Renewals and Full AUP Renewals - will be
submitted and attended to within timeframes outlined by the ACC.
e) http://uwo.ca/research/services/animalethics/animal_use_protocols.html
3) As per MAPP 7.10 all individuals listed within this AUP as having any hands-on animal contact will
a) be made familiar with and have direct access to this AUP;
b) complete all required CCAC mandatory training (training@uwo.ca); and
c) be overseen by me to ensure appropriate care and use of animals.
4) As per MAPP 7.15,
a) Practice will align with approved AUP elements;
b) Unrestricted access to all animal areas will be given to ACVS Veterinarians and ACC
Leaders;
c) UCAC policies and related ACC procedures will be followed, including but not limited
to:
i) Research Animal Procurement
ii) Animal Care and Use Records
iii) Sick Animal Response
iv) Continuing Care Visits
5) As per institutional OH&S policies, all individuals listed within this AUP who will be using or potentially
exposed to hazardous materials will have completed in advance the appropriate institutional OH&S
training, facility-level training, and reviewed related (M)SDS Sheets,
http://www.uwo.ca/hr/learning/required/index.html
Submitted by: Copeman, Laura
on behalf of the Animal Care Committee
University Council on Animal Care

Dr.Timothy Regnault,
Animal Care Committee Chair
The University of Western Ontario
Animal Care Committee / University Council on Animal Care
London, Ontario Canada N6A 5C1
519-661-2111 x 88792 Fax 519-661-2028
ï¿½ http://www.uwo.ca/research/services/animalethics/index.html
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AUP Number: 2017-108
PI Name: Strong, Michael
AUP Title: Somatic gene transfer to express Thr175Asp-tau, Thr175Ala-tau or wild-type tau in rat
hippocampus.
Approval Date: 02/01/2018
Official Notice of Animal Care Committee (ACC) Approval:
Your new Animal Use Protocol (AUP) 2017-108:1: entitled " Somatic gene transfer to express Thr175Asp-tau,
Thr175Ala-tau or wild-type tau in rat hippocampus."
has been APPROVED by the Animal Care Committee of the University Council on Animal Care. This approval, although
valid for up to four years, is subject to annual Protocol Renewal.
Prior to commencing animal work, please review your AUP with your research team to ensure full understanding by
everyone listed within this AUP.
As per your declaration within this approved AUP, you are obligated to ensure that:
1) Animals used in this research project will be cared for in alignment with:
a) Western's Senate MAPPs 7.12, 7.10, and 7.15
http://www.uwo.ca/univsec/policies_procedures/research.html
b) University Council on Animal Care Policies and related Animal Care Committee procedures
http://uwo.ca/research/services/animalethics/animal_care_and_use_policies.htm
2) As per UCAC's Animal Use Protocols Policy,
a) this AUP accurately represents intended animal use;
b) external approvals associated with this AUP, including permits and scientific/departmental peer approvals,
are complete and accurate;
c) any divergence from this AUP will not be undertaken until the related Protocol Modification is approved by
the ACC; and
d) AUP form submissions - Annual Protocol Renewals and Full AUP Renewals - will be submitted and attended
to within timeframes outlined by the ACC.
e) http://uwo.ca/research/services/animalethics/animal_use_protocols.html
3) As per MAPP 7.10 all individuals listed within this AUP as having any hands-on animal contact will
a) be made familiar with and have direct access to this AUP;
b) complete all required CCAC mandatory training (training@uwo.ca); and
c) be overseen by me to ensure appropriate care and use of animals.
4) As per MAPP 7.15,
a) Practice will align with approved AUP elements;
b) Unrestricted access to all animal areas will be given to ACVS Veterinarians and ACC Leaders;
c) UCAC policies and related ACC procedures will be followed, including but not limited to:
i) Research Animal Procurement
ii) Animal Care and Use Records
iii) Sick Animal Response
iv) Continuing Care Visits
5) As per institutional OH&S policies, all individuals listed within this AUP who will be using or potentially exposed to
hazardous materials will have completed in advance the appropriate institutional OH&S training, facility-level training,
and reviewed related (M)SDS Sheets,
http://www.uwo.ca/hr/learning/required/index.html
Submitted by: Copeman, Laura
on behalf of the Animal Care Committee
University Council on Animal Care

Dr.Timothy Regnault,
Animal Care Committee Chair
The University of Western Ontario
Animal Care Committee / University Council on Animal Care
London, Ontario Canada N6A 5C1
519-661-2111 x 88792 Fax 519-661-2028
auspc@uwo.ca http://www.uwo.ca/research/services/animalethics/index.html
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